ethinyl estradiol has been researched along with Polycystic Ovary Syndrome in 239 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 41 (17.15) | 18.7374 |
| 1990's | 17 (7.11) | 18.2507 |
| 2000's | 74 (30.96) | 29.6817 |
| 2010's | 93 (38.91) | 24.3611 |
| 2020's | 14 (5.86) | 2.80 |
| Authors | Studies |
|---|---|
| Álvarez-Blasco, F; de Lope Quiñones, S; Escobar-Morreale, HF; Fernández-Durán, E; Insenser, M; Luque-Ramírez, M; Martínez-García, MÁ; Nattero-Chávez, L; Ortiz-Flores, AE; Quintero-Tobar, A | 1 |
| Basciani, S; Khomasuridze, A; Nordio, M; Pkhaladze, L; Russo, M; Unfer, V | 1 |
| Chen, X; Feng, Y; Li, X; Liu, Y; Wang, Y; Yao, D; Zhang, F | 1 |
| Chen, Y; Li, L; Li, Y; Miao, H; Ou, Y; Peng, X; Song, Y; Zhang, X; Zhou, J | 1 |
| Alesi, S; Forslund, M; Melin, J; Mousa, A; Pena, A; Piltonen, T; Romualdi, D; Tay, CT; Teede, H; Witchel, S | 1 |
| Chen, Z; Huang, L; Ke, H; Li, L; Li, TT; Li, X; Peng, X; Tan, Q; Yang, Y; Zeng, J; Zhang, H; Zhang, R | 1 |
| Cereijo, R; de Zegher, F; García-Beltran, C; Ibáñez, L; López-Bermejo, A; Malpique, R; Quesada-López, T; Villarroya, F | 1 |
| Huo, P; Jiang, Z; Le, J; Lei, X; Tang, Q; Tu, H; Yao, J; Zhang, R; Zhang, S | 1 |
| Artini, PG; Battaglia, B; Battaglia, C; Casadio, P; Rizzo, R | 1 |
| Deng, Y; Ma, RL; Ma, X; Sun, AJ; Wang, YF; Xue, W; Zhu, SY | 1 |
| Hu, H; Liu, Z; Song, Y; Wang, J; Weng, Y; Xu, Y | 1 |
| Hu, H; Li, F; Li, W; Liu, J; Ma, Z; Zou, G | 1 |
| Bajpai, G; Varma, E; Varma, PP | 1 |
| Abdel-Maboud, M; Abdelraoof, MI; Alshandidy, M; Eid, M; Hasabo, EA; Menshawy, A; Menshawy, E; Outani, O | 1 |
| Aguilar, A; Kubba, A; Mueck, AO; Ruan, X | 1 |
| Mueck, AO | 1 |
| de Zegher, F; Del Río, L; Díaz, M; Ibáñez, L; López-Bermejo, A; Pozo, ÓJ; Sebastiani, G | 1 |
| Andersen, M; Christensen, MMH; Glintborg, D; Pedersen, AJT; Stage, TB | 1 |
| Araujo Castro, M; Campos Del Portillo, R; Izquierdo Álvarez, C; Oliván Palacios, B; Prieto Coca, L | 1 |
| Gu, M; Mueck, AO; Ruan, X; Song, J; Wang, H; Wang, L | 2 |
| Cao, Y; Liu, Z; Zhang, L; Zhao, D | 1 |
| Amiri, M; Kabir, A; Nahidi, F; Ramezani Tehrani, F; Shekofteh, M | 1 |
| Cai, G; Du, J; Li, X; Li, Y; Mueck, AO; Ruan, X; Wang, H; Wang, L; Zhao, Y | 1 |
| Bodur, S; Dundar, O; Kanat-Pektas, M; Kinci, MF; Tutuncu, L | 1 |
| Mohanty, J; Nagy, A; Sahu, A; Tripathy, P | 1 |
| Emekçi Özay, Ö; Gülekli, B; Okyay, RE; Özay, AC | 1 |
| Shi, Y; Tang, L; Ye, J; Zhu, X | 1 |
| Bender, JR; Leone, CA; Stachenfeld, NS; Steele, FE; Taylor, HS; Usselman, CW; Yarovinsky, TO | 1 |
| Cao, Y; Chen, H; Liu, Z; Yu, X; Zhang, L; Zhao, D; Zhou, X | 1 |
| Chen, H; Cheng, NCL; Lim, CED; Ng, RWC; Zhang, GS | 1 |
| Amin, S; Bhat, IA; Fatima, Q; Ganie, MA; Jeelani, H; Kawa, IA; Manzoor, S; Rashid, F; Shah, ZA; Yousuf, SD | 1 |
| Apa, R; Ciardulli, A; Cosentino, N; Crea, F; Familiari, A; Lanzone, A; Liuzzo, G; Martinez, D; Morciano, A; Moro, F; Niccoli, G; Palla, C; Sagnella, F; Scarinci, E; Tritarelli, A; Tropea, A | 1 |
| Açmaz, G; Boztosun, A; Müderris, II; Ozturk, A | 1 |
| Decanter, C; Dewailly, D; Lefebvre, C; Lefebvre-Khalil, V; Leroy, M; Leroy-Martin, B; Robin, G; Soudan, B; Thomas, P | 1 |
| Akdeniz, D; Carlioglu, A; Gumus, II; Karakurt, F; Kaygusuz, I; Uz, B | 1 |
| Aksoy, DY; Arusoglu, G; Cinar, N; Koksal, G; Tapan, S; Yildiz, BO | 1 |
| Busacca, M; De Cicco, S; Gagliano, D; Guido, M; Lanzone, A; Romualdi, D | 1 |
| Chan, SS; Chung, JP; Chung, TK; Yiu, AK | 1 |
| Atabekoğlu, CS; Ateş, C; Berker, B; Cetinkaya, SE; Kahraman, K; Ozmen, B; Sönmezer, M; Sükür, YE; Taşkın, S; Tolunay, HE | 1 |
| Bowden, SA; Henry, RK | 1 |
| Borghi, C; Cicero, AF; Grandi, E; Morbini, M; Parini, A; Reggi, A; Rosticci, M | 1 |
| Altinok, ML; Andersen, M; Glintborg, D; Hermann, AP; Mumm, H; Ravn, P | 1 |
| Armutcu, F; Carlioglu, A; Gumus, II; Karakurt, F; Kasapoglu, B; Kaygusuz, I; Keskin, EA; Koca, C; Uysal, A; Uysal, S | 1 |
| Altinok, ML; Andersen, M; Bruun, JM; Glintborg, D; Mumm, H; Richelsen, B | 1 |
| Acet, F; Bodur, T; Cagliyan, E; Gode, F; Gulekli, B; Okyay, E; Posaci, C; Sahan, C | 1 |
| Jongwutiwes, T; Leelaphiwat, S; Lertvikool, S; Rattanasiri, S; Sukprasert, M; Tabcharoen, C; Weerakiet, S | 1 |
| Aksoy, A; Carlioglu, A; Gozukara, I; Kabil Kucur, S; Kamalak, Z; Keskin, H; Uludag, EU | 1 |
| Atabekoğlu, CS; Ateş, C; Berker, B; Ozmen, B; Seval, MM; Sönmezer, M; Sükür, YE | 1 |
| Cim, N; Gokce, AI; Yildizhan, B; Yildizhan, R | 1 |
| Akpek, M; Calapkorur, B; Kaya, MG; Kelestimur, F; Unluhizarci, K; Yildirim, S | 1 |
| Cahill, DJ; O'Brien, K | 1 |
| Jin, CL; Wei, LX; Wu, ZC; Zhao, JP | 1 |
| Jin, J; Mueck, AO; Ruan, X; Wu, H | 1 |
| Chen, A; Du, J; Du, Y; Liao, YC; Lin, XF; Wang, Y; Wu, C; Wu, RR; Ye, Y; Zhang, XB | 1 |
| Altinok, ML; Andersen, M; Glintborg, D; Mumm, H; Sidelmann, JJ | 1 |
| Sun, X; Wu, X; Yu, X; Zhang, W; Zhou, Y | 1 |
| Ahmadi, F; Ahmadi, J; Akhoond, MR; Jahangiri, N; Moini, A | 1 |
| Feng, W; Jia, YY; Shi, HR; Zhang, DY | 1 |
| Bhattacharya, SM; DasMukhopadhyay, L; Jha, A | 1 |
| Adeniji, AA; Cheang, KI; Essah, PA; Nestler, JE | 1 |
| Mao, XG; Tu, AS; Zhong, Y | 1 |
| Bottiglieri, P; Colao, A; Colarieti, G; Giallauria, F; Muscogiuri, G; Orio, F; Palomba, S; Predotti, P; Savastano, S; Tafuri, D | 1 |
| Ganie, MA; Mattoo, T; Mudassar, S; Rashid, F; Shekhar, C; Yousuf, SD; Zargar, MA | 1 |
| Chang, HY; Chen, CH; Chen, HH; Chin, HY; Liu, WM | 1 |
| Lim, CE; Wu, T; Xu, L; Zhang, J; Zhou, K | 1 |
| Asiimwe, A; Cea Soriano, L; García Rodriguez, LA | 1 |
| Cui, N; Feng, X; Hao, G; Wang, L; Xu, Y; Zhang, J; Zhao, Z | 1 |
| Ozdemir, M; Ozdemir, S; Toy, H | 1 |
| Jiang, M; Ma, F; Qi, J; Qiao, L; Wang, L; Xie, S; Xu, K; Yue, H; Zhang, W; Zhou, X | 1 |
| Alvarez-Blasco, F; Escobar-Morreale, HF; Luque-Ramírez, M; Mendieta-Azcona, C | 1 |
| Liao, H; Luo, WY; Sun, Y; Wang, CF; Zhang, D | 1 |
| Cao, Y; Jiang, Y; Wu, J; Zhu, Y | 1 |
| Gezginç, K; Görkemli, H; Kiyici, A; Ozdemir, M; Ozdemir, S | 1 |
| Akcay, A; Bavbek, N; Gumus, II; Karakurt, F; Kargili, A; Koca, C; Kosar, A; Ozbek, M; Selcoki, Y | 1 |
| Jing, Z; Liang-Zhi, X; Tai-Xiang, W; Ying, T; Yu-Jian, J | 1 |
| Hutchison, SK; McGrath, BP; Meyer, C; Moran, LJ; Teede, HJ; Zoungas, S | 1 |
| del Rey Sánchez, JM; Escobar-Morreale, HF; Luque-Ramírez, M; Matíes, M; Mendieta-Azcona, C | 1 |
| Alacacioglu, A; Kebapcilar, AG; Kebapcilar, L; Sari, I; Taner, CE | 1 |
| Gaillard, RC; Gomez, F; Karrer-Voegeli, S; Meuwly, JY; Rey, F; Reymond, MJ | 1 |
| Battaglia, C; Busacchi, P; Fabbri, R; Facchinetti, F; Mancini, F; Persico, N; Venturoli, S | 1 |
| Bilgir, F; Bilgir, O; Bozkaya, G; Kebapcilar, A; Kebapcilar, L; Sari, I; Taner, C; Yildiz, Y; Yuksel, A | 1 |
| Alacacioglu, A; Bilgir, O; Kebapcilar, AG; Kebapcilar, L; Kozaci, DL; Sari, I; Taner, CE; Yildiz, Y; Yuksel, A | 1 |
| Caruso, S; Cianci, A; De Leo, V; Scolaro, V | 1 |
| Fruzzetti, F; Gambacciani, M; Genazzani, AR; Lazzarini, V; Parrini, D; Perini, D | 1 |
| Chen, HF; Chen, MJ; Chen, SU; Ho, HN; Kuo, JJ; Yang, WS; Yang, YS | 1 |
| Goulis, DG; Makedos, A; Panidis, D; Papanikolaou, A | 1 |
| De Zegher, F; Del Río, L; Díaz, M; Enríquez, G; Ibáñez, L; López-Bermejo, A | 1 |
| Bilgir, O; Bozkaya, G; Kebapcilar, AG; Kebapcilar, L; Sari, I; Taner, CE; Yildiz, Y | 1 |
| Bompiani, A; Campagna, G; Guido, M; Lanzone, A; Ricciardi, L; Romualdi, D | 1 |
| Artini, PG; Battaglia, B; Battaglia, C; Facchinetti, F; Mancini, F; Venturoli, S | 1 |
| Agarwal, N; Ammini, AC; Kriplani, A; Kulshrestha, V; Kumar, A; Periyasamy, AJ | 1 |
| Etzi, R; Guerriero, S; Lello, S; Marotto, MF; Melis, GB; Orrù, M; Pani, F; Paoletti, AM; Pilloni, M; Sorge, R; Uras, R; Zedda, P | 1 |
| Cianci, A; De Leo, V; Di Sabatino, A; Morgante, G; Musacchio, MC; Petraglia, F; Scolaro, V | 1 |
| Decavalas, G; Diamanti-Kandarakis, E; Georgopoulos, NA; Katsikis, I; Panidis, D; Piouka, A; Saltamavros, AD | 1 |
| Akdeniz, B; Gode, F; Karagoz, C; Posaci, C; Saatli, B; Secil, M; Uysal, D | 1 |
| Arslanian, S; Lee, S; Sutton-Tyrrell, K; Tfayli, H; Ulnach, JW | 1 |
| Bechlioulis, A; Kalantaridou, SN; Katsouras, CS; Kazakos, N; Kravariti, M; Michalis, LK; Naka, KK; Tsatsoulis, A | 1 |
| Biringer, K; Biringerová, Z; Svecová, I; Visnovský, J | 1 |
| Aksoy, ON; Cakir, O; Colak, N; Nazli, Y | 1 |
| Adonakis, G; Armeni, AK; Decavalas, G; Georgopoulos, NA; Karela, A; Markantes, G; Saltamavros, AD; Vervita, V | 1 |
| Adawadkar, SS; Arrowood, JA; Cheang, KI; Essah, PA; Nestler, JE; Stovall, DW | 1 |
| Banaszewska, B; Ozegowska, K; Pawelczyk, L; Spaczyński, RZ | 1 |
| Gui, SQ; Kuek, S; Wang, WJ | 1 |
| Demirlenk, S; Karabulut, A; Sevket, O | 1 |
| Basu, R; Bhattacharya, SM; Ghosh, M | 1 |
| Lages, L; Maier, PS; Mattiello, SS; Spritzer, PM | 1 |
| Pepene, CE | 1 |
| de Sá, MF; dos Reis, RM; Fernandes, JB; Ferriani, RA; Martins, WP; Soares, GM; Vieira, CS | 1 |
| Cinar, N; Demir, B; Harmanci, A; Yildiz, BO | 1 |
| Bayraktar, M; Cinar, N; Harmanci, A; Yildiz, BO | 2 |
| Belo, VA; Ferriani, RA; França, JB; Gomes, VA; Jacob-Ferreira, AL; Soares, GM; Tanus-Santos, JE; Vieira, CS | 1 |
| Akpek, M; Calapkorur, B; Celik, A; Karaca, Z; Kaya, MG; Kelestimur, F; Unluhizarci, K; Yildirim, S | 1 |
| Haydardedeoglu, B; Kilicdag, EB; Parlakgumus, AH; Zeyneloglu, HB | 1 |
| DiVasta, AD; Veilleux-Lemieux, M | 1 |
| Maier, PS; Spritzer, PM | 1 |
| Aksoy, DY; Aydin, K; Bozdag, G; Cinar, N; Yildiz, BO | 1 |
| Cakiroglu, Y; Isgoren, S; Vural, B | 1 |
| Carranza-Lira, S; Magaña-Padilla, NR | 1 |
| Koivunen, R; Martikainen, H; Morin-Papunen, L; Ruokonen, A; Tapanainen, JS; Vauhkonen, I | 1 |
| de Vries, CS; Farmer, RD; Seaman, HE | 3 |
| Dahlgren, E; Holm, G; Janson, PO; Krotkiewski, M; Landin, K | 2 |
| Koyuncu, FM; Kuscu, NK; Onur, E; Var, A | 1 |
| Cagnacci, A; Melis, GB; Orrù, M; Paoletti, AM; Pilloni, M; Renzi, A; Volpe, A | 1 |
| Fleming, R; Harborne, L; Lyall, H; Norman, J; Sattar, N | 1 |
| CHAPDELAINE, A; LANTHIER, A; SANDOR, T | 1 |
| CRANE, MG; HARRIS, JJ | 1 |
| MAGGIOLO, J | 1 |
| Hedberg, P; Morin-Papunen, L; Puukka, M; Rautio, K; Ruokonen, A; Tapanainen, JS | 1 |
| Harma, M; Kilic, F; Nazligul, Y; Sabuncu, T | 1 |
| Herer, P; Luboshitzky, R; Nave, R; Shen-Orr, Z | 1 |
| Herer, P; Luboshitzky, R; Shen-Orr, Z | 1 |
| Cascella, T; Colao, A; Di Biase, S; Labella, D; Lombardi, G; Orio, F; Palomba, S; Pellicano, M; Russo, T; Savastano, S; Tauchmanovà, L; Zullo, F | 1 |
| de Zegher, F; Ibáñez, L | 3 |
| Apa, R; Giuliani, M; Guido, M; Lanzone, A; Romualdi, D; Selvaggi, L; Suriano, R | 1 |
| Bahceci, M; Bahceci, S; Bilge, M; Tuzcu, A; Tuzcu, S | 1 |
| Chen, CY; Chen, PH; Hsieh, BC; Huang, LW; Huang, SC; Hwang, JL; Lin, YH; Seow, KM; Tsai, YL; Tzeng, CR; Wu, GJ | 1 |
| Mitkov, M; Pekhlivanov, B; Terzieva, D | 1 |
| Cabré, S; De Zegher, F; Ibáñez, L; Valls, C | 1 |
| Beigi, A; Sobhi, A; Zarrinkoub, F | 1 |
| Mitkov, M; Pehlivanov, B; Terzieva, D | 1 |
| Arteaga, E; Cárdenas, I; Hormaza, P; Oestreicher, E; Villaseca, P | 1 |
| Bhathena, RK | 1 |
| Morin-Papunen, LC; Rautio, K; Ruokonen, A; Tapanainen, JS | 1 |
| Al-Inany, H | 2 |
| Déchêne, F; Dodin, S; Forest, JC; Lemay, A; Turcot, L | 1 |
| Chen, LS; Zhou, JT | 1 |
| Inal, MM; Taner, CE; Yildirim, Y | 1 |
| Cagnacci, A; Paoletti, AM; Renzi, A; Tirelli, A; Volpe, A | 1 |
| Banaszewska, B; Duleba, AJ; Dziura, J; Pawelczyk, L; Spaczynski, RZ | 1 |
| Centeno, I; David, M; Gutierrez, E; Kahi, D; Pérez, M; Sánchez, LA | 1 |
| Foltyn, W; Kos-Kudła, B; Kudła, M; Mazur, B; Małecka-Mikosz, O; Ostrowska, Z | 1 |
| Dvorakova, K; Hill, M; Starka, L; Vrbikova, J | 1 |
| Schattmann, L; Sherwin, BB | 1 |
| Cianci, A; De Leo, V; Morgante, G; Musacchio, MC; Petraglia, F; Piomboni, P | 1 |
| Charitidou, C; Farmakiotis, D; Hatzistilianou, M; Karamanis, N; Katsikis, I; Panidis, D; Pegiou, T; Pidonia, I; Zournatzi, V | 1 |
| Alvarez-Blasco, F; Botella-Carretero, JI; Escobar-Morreale, HF; Lasunción, MA; Luque-Ramírez, M; Martínez-Bermejo, E | 1 |
| Mitkov, M; Pehlivanov, B | 1 |
| Atanasova, I; Genchev, G; Kamenov, Z; Khristov, V; Kolarov, G; Milcheva, B; Orbetsova, M; Shigarminova, R; Zakharieva, S | 1 |
| Alvarez-Blasco, F; Botella-Carretero, JI; Escobar-Morreale, HF; Luque-Ramírez, M; San Millán, JL; Sanchón, R | 1 |
| Demirci, F; Gul, OB; Ozdemir, I; Somunkiran, A; Yucel, O | 1 |
| Franks, S; Glasier, A; Layton, A | 1 |
| Baser, I; Dede, M; Erbil, MK; Kenar, L; Oktenli, C; Ozgurtas, T; Sanisoglu, SY; Tapan, S; Yenen, MC; Yesilova, Z | 1 |
| Yildiz, BO | 1 |
| Alvarez-Blasco, F; Escobar-Morreale, HF; Luque-Ramírez, M; Uriol Rivera, MG | 1 |
| Bakalianou, K; Creatsas, G; Gregoriou, O; Konidaris, S; Papadias, K; Salakos, N; Vrachnis, N | 1 |
| Harrison, C; Hutchison, SK; Meyer, C; Stepto, N; Teede, HJ | 1 |
| Fogel, M; Soffer, LJ | 1 |
| Antonelli, S; Barletta, C; Buzzetti, R; Dino, N; Giovannini, C; Raccamarich, I; Tarasco, A | 1 |
| Baxendale, PM; Jacobs, HS; James, VH | 2 |
| McDonough, PG; Reindollar, RH | 1 |
| Campo, S; Garcea, N; Giacchi, E; Messina, M; Moneta, E; Panetta, V | 1 |
| Barnabé, S; Fabbri, R; Flamigni, C; Paradisi, R; Porcu, E; Saviotti, E; Venturoli, S | 1 |
| Ginsburg, J; White, MC | 1 |
| Chaudhuri, N; Ghose, D; Kundu, D; Mitra, K; Mondal, S | 1 |
| Hicks, B; Raj, MH; Raj, SG; Sloan, CS; Talbert, LM | 1 |
| Falsetti, L; Pasinetti, E | 1 |
| Aravantinos, D; Creatsas, G; Deligeoroglou, E; Hassan, E; Tolis, G | 1 |
| Aglianò, A; Cianci, A; Ciotta, L; Marletta, E; Palumbo, G; Pisana, L | 1 |
| Balint-Perić, LA; Prelević, GM; Puzigaća, Z | 1 |
| Elstein, ME; Golland, IM | 1 |
| Aglianò, A; Cianci, A; Ciotta, L; Giuffrida, G; Marletta, E; Palumbo, G | 1 |
| Acién, P; Gutierrez, M; Mauri, M | 1 |
| Dramusic, V; Goh, VH; Rajan, U; Ratnam, SS; Wong, YC | 1 |
| Arner, P; Bergqvist, A; Carlström, K; Ek, I; Reynisdottir, S; Wahrenberg, H | 1 |
| Gjønnaess, H | 1 |
| Kokaly, W; McKenna, TJ | 1 |
| Cicinelli, E; D'Addario, V; De Pergola, G; De Salvia, MA; Schonauer, LM; Tartagni, M | 1 |
| Lhullier, F; Lisboa, KO; Mattiello, S; Spritzer, PM | 1 |
| Creatsas, G; Koliopoulos, C; Mastorakos, G | 2 |
| Koivunen, RM; Martikainen, HK; Morin-Papunen, LC; Ruokonen, A; Tapanainen, JS; Vauhkonen, I | 1 |
| Kleinstein, J; Muenstermann, U | 1 |
| Falsetti, L; Gambera, A; Tisi, G | 1 |
| Armstrong, VL; Atkinson, AB; Bell, PM; Ennis, CN; Sheridan, B; Traub, AI; Wiggam, MI | 1 |
| Caruso, A; De Leo, V; Fulghesu, AM; la Marca, A; Morgante, G; Pasqui, L; Talluri, B; Torricelli, M | 1 |
| Durmusoglu, F; Elter, K; Imir, G | 1 |
| van den Ende, A; van Wayjen, RG | 1 |
| Frölich, M; Lachinsky, N; Moolenaar, AJ | 1 |
| Baird, DT; Corker, CS; Davidson, DW; Hunter, WM; Michie, EA; Van Look, PF | 1 |
| Kuttenn, F; Lecomte, P; Mandelbaum, J; Mauvais-Jarvis, P; Mowszowicz, I | 1 |
| Sloan, C; Talbert, LM | 1 |
| Ginsburg, J; Havard, CW | 1 |
| Macnaughton, MC | 1 |
| Andersen, RN; Givens, JR; Umstot, ES; Wiser, WL | 1 |
| Laatikainen, T; Seppälä, M; Stenman, UH; Suikkari, AM; Tiitinen, A | 1 |
| Giagulli, VA; Giorgino, R; Vermeulen, A | 1 |
| Eden, JA | 1 |
| Falsetti, L; Galbignani, E | 1 |
| Conway, GS; Jacobs, HS | 1 |
| Balint-Perić, L; Prelević, GM; Trpković, D; Würzburger, MI | 1 |
| Balint-Perić, L; Prelević, GM; Puzigaća, Z; Würzburger, MI | 1 |
| Perić, L; Prelević, G; Würzburger, M | 1 |
| Bovicelli, L; Fabbri, R; Flamigni, C; Orsini, LF; Paradisi, R; Porcu, E; Saviotti, E; Venturoli, S | 1 |
| Cabero-Roura, A; Calaf-Alsina, J; Esteban-Altirriba, J; Lenti-Paoli, O; Mora-Brugues, J; Rodriguez-Espinosa, J | 1 |
| Farace, MJ; Leone, F; Minutolo, M; Montemagno, U; Nappi, C; Tommaselli, AP | 1 |
| Chailurkit, L; Chaturachinda, K; Rojanasakul, A; Sirimongkolkasem, R | 1 |
| Chailurkit, L; Chaturachinda, K; Piromsawasdi, S; Rojanasakul, A; Sirimongkolkasem, R; Sumavong, V | 1 |
| D'Errico, G; Minisci, N; Negri, P; Tomasi, A | 1 |
| Anderson, DC; Evans, A; Mamtora, H; Mavroudis, K; Robertson, WR | 1 |
| Cullberg, G; Hamberger, L; Mattsson, LA; Mobacken, H; Samsioe, G | 2 |
| Cullberg, G | 1 |
| Edwards, A; Fairhall, KM; Lightman, SL; McGarrick, GM; Robinson, IC; Williams, TD | 1 |
| Mauvais-Jarvis, P | 1 |
| Andersen, RN; Coleman, SA; Fish, SA; Givens, JR; Kerber, IJ; Wiser, WL | 1 |
| Hancock, KW; Levell, MJ | 1 |
| Jaffe, RB; Midgley, AR | 1 |
| Bardin, CW; Hembree, WC; Kirschner, MA; Ross, GT | 1 |
| Bengtsson, LP; Moawad, AH | 1 |
| Bercovici, JP; Floch, HH; Mauvais-Jarvis, P | 1 |
13 review(s) available for ethinyl estradiol and Polycystic Ovary Syndrome
| Article | Year |
|---|---|
Different kinds of oral contraceptive pills in polycystic ovary syndrome: a systematic review and meta-analysis.
Topics: Contraceptives, Oral, Combined; Cyproterone Acetate; Ethinyl Estradiol; Female; Hirsutism; Humans; Hyperandrogenism; Polycystic Ovary Syndrome; Testosterone | 2023 |
The comparative effectiveness of 55 interventions in obese patients with polycystic ovary syndrome: A network meta-analysis of 101 randomized trials.
Topics: Adult; Body Mass Index; Cholesterol, LDL; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Network Meta-Analysis; Obesity; Overweight; Polycystic Ovary Syndrome; Randomized Controlled Trials as Topic; Testosterone; Treatment Outcome; Triglycerides; Waist-Hip Ratio | 2021 |
Use of cyproterone acetate/ethinylestradiol in polycystic ovary syndrome: rationale and practical aspects.
Topics: Acne Vulgaris; Adult; Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Hirsutism; Humans; Polycystic Ovary Syndrome; Treatment Outcome | 2017 |
Effects of combined oral contraceptives on the clinical and biochemical parameters of hyperandrogenism in patients with polycystic ovary syndrome: a systematic review and meta-analysis.
Topics: Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Hirsutism; Humans; Hyperandrogenism; Polycystic Ovary Syndrome; Progestins; Regression Analysis; Sex Hormone-Binding Globulin; Treatment Outcome | 2018 |
Acupuncture for polycystic ovarian syndrome.
Topics: Abortion, Spontaneous; Acupuncture Therapy; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Infertility, Female; Menstruation; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Outcome; Pregnancy Rate; Pregnancy, Multiple; Randomized Controlled Trials as Topic | 2019 |
Chinese herbal medicine for subfertile women with polycystic ovarian syndrome.
Topics: Adult; Clomiphene; Cyproterone Acetate; Drugs, Chinese Herbal; Ethinyl Estradiol; Female; Fertility Agents, Female; Humans; Infertility; Laparoscopy; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Rate; Randomized Controlled Trials as Topic; Suction | 2016 |
The effects of Diane-35 and metformin in treatment of polycystic ovary syndrome: an updated systematic review.
Topics: Algorithms; Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Metformin; Polycystic Ovary Syndrome; Treatment Outcome | 2008 |
[Low dose oral contraceptives: 30 microg are still used?].
Topics: Androgen Antagonists; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Ovarian Cysts; Patient Acceptance of Health Care; Polycystic Ovary Syndrome; Progesterone Congeners; Sex Hormone-Binding Globulin; Thrombophilia; Weight Gain | 2009 |
Polycystic ovary syndrome.
Topics: Androgen Antagonists; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Finasteride; Flutamide; Hirsutism; Humans; Metformin; Polycystic Ovary Syndrome; Spironolactone | 2004 |
Polycystic ovary syndrome.
Topics: Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Finasteride; Flutamide; Humans; Metformin; Polycystic Ovary Syndrome; Spironolactone | 2005 |
Hirsutism and virilisation.
Topics: Androgens; Drug Therapy, Combination; Ethinyl Estradiol; Female; Hair Removal; Hirsutism; Humans; Polycystic Ovary Syndrome; Prednisolone; Virilism | 1980 |
Polycystic ovary syndrome.
Topics: Bromocriptine; Clomiphene; Dexamethasone; Diagnosis, Differential; Drug Combinations; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Ketosteroids; Luteinizing Hormone; Medroxyprogesterone; Ovary; Polycystic Ovary Syndrome; Prednisone; Testosterone; Time Factors | 1976 |
Current status of human gonadotropin radioimmunoassay.
Topics: Chorionic Gonadotropin; Clomiphene; Dimethisterone; Dydrogesterone; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Intrauterine Devices; Luteinizing Hormone; Male; Menstruation; Norethindrone; Ovulation; Polycystic Ovary Syndrome; Pregnanediol; Radioimmunoassay | 1969 |
111 trial(s) available for ethinyl estradiol and Polycystic Ovary Syndrome
| Article | Year |
|---|---|
Bloodletting has no effect on the blood pressure abnormalities of hyperandrogenic women taking oral contraceptives in a randomized clinical trial.
Topics: Adult; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Bloodletting; Contraceptives, Oral, Combined; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Hypertension; Polycystic Ovary Syndrome; Young Adult | 2021 |
Treatment of lean PCOS teenagers: a follow-up comparison between Myo-Inositol and oral contraceptives.
Topics: Adolescent; Age Factors; Androstenes; Body Mass Index; Contraceptives, Oral; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Inositol; Polycystic Ovary Syndrome; Thinness; Young Adult | 2021 |
Reduced circulating levels of chemokine CXCL14 in adolescent girls with polycystic ovary syndrome: normalization after insulin sensitization.
Topics: Adipocytes; Adipogenesis; Adipose Tissue, Brown; Adolescent; Arrhythmias, Cardiac; Biomarkers; Chemokines, CXC; Contraceptives, Oral, Hormonal; Drug Therapy, Combination; Ethinyl Estradiol; Female; Gene Expression; Genetic Diseases, X-Linked; Gigantism; Heart Defects, Congenital; Humans; Hypoglycemic Agents; Insulin Resistance; Intellectual Disability; Levonorgestrel; Metformin; Mineralocorticoid Receptor Antagonists; Pioglitazone; Polycystic Ovary Syndrome; Spironolactone; Treatment Outcome | 2020 |
Is There An Advantage of Using Dingkun Pill () alone or in Combination with Diane-35 for Management of Polycystic Ovary Syndrome? A Randomized Controlled Trial.
Topics: Adult; Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Drug Therapy, Combination; Drugs, Chinese Herbal; Ethinyl Estradiol; Female; Humans; Polycystic Ovary Syndrome; Prospective Studies; Young Adult | 2020 |
The comparison of the effectiveness and safety of drospirone ethinyl estradiol and ethinyl estradiol cyproterone in the treatment of polycystic ovarian syndrome: A protocol for systematic review and meta-analysis.
Topics: Adult; Androstenes; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; Meta-Analysis as Topic; Polycystic Ovary Syndrome; Systematic Reviews as Topic; Treatment Outcome | 2020 |
Therapeutic effects of puerarin on polycystic ovary syndrome: A randomized trial in Chinese women.
Topics: Administration, Oral; Adolescent; Adult; China; Cholesterol; Cyproterone Acetate; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Isoflavones; Metformin; Obesity; Polycystic Ovary Syndrome; Primary Ovarian Insufficiency; Sex Hormone-Binding Globulin; Superoxide Dismutase; Tablets; Testosterone; Treatment Outcome; Young Adult | 2021 |
Normalizing Ovulation Rate by Preferential Reduction of Hepato-Visceral Fat in Adolescent Girls With Polycystic Ovary Syndrome.
Topics: Adolescent; Body Mass Index; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Female; Hirsutism; Humans; Hypoglycemic Agents; Infertility, Female; Intra-Abdominal Fat; Levonorgestrel; Metformin; Oligomenorrhea; Ovulation; Pioglitazone; Polycystic Ovary Syndrome; Spironolactone; Thiazolidinediones | 2017 |
The Pharmacogenetics of Metformin in Women with Polycystic Ovary Syndrome: A Randomized Trial.
Topics: Adult; Ataxia Telangiectasia Mutated Proteins; Biomarkers; Blood Glucose; Contraceptives, Oral, Hormonal; Desogestrel; Drug Therapy, Combination; Ethinyl Estradiol; Female; Hepatocyte Nuclear Factor 1-alpha; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Metformin; Organic Anion Transport Protein 1; Organic Cation Transport Proteins; Pharmacogenetics; Pharmacogenomic Variants; Polycystic Ovary Syndrome; Time Factors; Treatment Outcome; Triglycerides; Weight Loss; Young Adult | 2018 |
[
Topics: Acupuncture Points; Acupuncture Therapy; Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menstrual Cycle; Ovary; Pilot Projects; Polycystic Ovary Syndrome | 2017 |
Effect of Diane-35, alone or in combination with orlistat or metformin in Chinese polycystic ovary syndrome patients.
Topics: Adipose Tissue; Adult; Androgen Antagonists; Androgens; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Insulin Resistance; Metformin; Obesity; Orlistat; Overweight; Polycystic Ovary Syndrome; Treatment Outcome | 2018 |
The effects of different therapeutic modalities on cardiovascular risk factors in women with polycystıc ovary syndrome: A randomızed controlled study.
Topics: Adult; Androstenes; Apolipoproteins B; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Drug Therapy, Combination; Ethinyl Estradiol; Female; Homocysteine; Humans; Hypoglycemic Agents; Insulin Resistance; Metabolic Syndrome; Metformin; Mineralocorticoid Receptor Antagonists; Peptide Fragments; Plasminogen Activator Inhibitor 1; Polycystic Ovary Syndrome; Reproductive Control Agents; Risk Factors; Young Adult | 2018 |
Doppler analysis of ovarian stromal blood flow changes after treatment with metformin versus ethinyl estradiol-cyproterone acetate in women with polycystic ovarian syndrome: A randomized controlled trial.
Topics: Adult; Androgen Antagonists; Androgens; Body Mass Index; Contraceptives, Oral, Combined; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Insulin; Insulin Resistance; Luteinizing Hormone; Metformin; Ovary; Polycystic Ovary Syndrome; Prospective Studies; Regional Blood Flow; Testosterone; Ultrasonography, Doppler, Color; Waist Circumference | 2019 |
The effect of myoinositol on ovarian blood flows in women with polycystic ovary syndrome.
Topics: Adult; Ethinyl Estradiol; Female; Humans; Inositol; Ovary; Polycystic Ovary Syndrome; Regional Blood Flow; Ultrasonography, Doppler, Color; Young Adult | 2019 |
Androgens drive microvascular endothelial dysfunction in women with polycystic ovary syndrome: role of the endothelin B receptor.
Topics: Adult; Androgens; Cardiovascular Diseases; Dihydrotestosterone; Endothelin-1; Endothelium, Vascular; Estrogens; Ethinyl Estradiol; Female; Glucose Tolerance Test; Humans; Microvessels; Nitric Oxide; Obesity; Polycystic Ovary Syndrome; Receptor, Endothelin B; Skin; Vascular Endothelial Growth Factor A; Vasodilation; Young Adult | 2019 |
The efficacy of Tung's acupuncture for sex hormones in polycystic ovary syndrome: A randomized controlled trial.
Topics: Acupuncture; Acupuncture Therapy; Adult; Body Mass Index; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Humans; Polycystic Ovary Syndrome | 2019 |
Effects of drospirenone-ethinylestradiol and/or metformin on CD4(+)CD28(null) T lymphocytes frequency in women with hyperinsulinemia having polycystic ovary syndrome: a randomized clinical trial.
Topics: Adolescent; Adult; Analysis of Variance; Androstenes; Cardiovascular Diseases; CD28 Antigens; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Chi-Square Distribution; Ethinyl Estradiol; Female; Humans; Hyperinsulinism; Hypoglycemic Agents; Metformin; Polycystic Ovary Syndrome; Reproductive Control Agents; Risk Factors; Rome; Time Factors; Treatment Outcome; Young Adult | 2013 |
First intention IVF protocol for polycystic ovaries: does oral contraceptive pill pretreatment influence COH outcome?
Topics: Adult; Androstenedione; Contraceptives, Oral; Desogestrel; Drug Administration Schedule; Drug Therapy, Combination; Embryo Transfer; Ethinyl Estradiol; Female; Fertilization in Vitro; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Rate; Prospective Studies; Recombinant Proteins; Testosterone; Treatment Outcome; Triptorelin Pamoate; Ultrasonography; Young Adult | 2013 |
Clinical efficacy and metabolic impact of two different dosages of ethinyl-estradiol in association with drospirenone in normal-weight women with polycystic ovary syndrome: a randomized study.
Topics: Adolescent; Adult; Androstenes; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Drug Combinations; Ethinyl Estradiol; Female; Glucose Clamp Technique; Hirsutism; Humans; Hyperandrogenism; Pilot Projects; Polycystic Ovary Syndrome; Triglycerides | 2013 |
A randomized crossover study of medroxyprogesterone acetate and Diane-35 in adolescent girls with polycystic ovarian syndrome.
Topics: Acne Vulgaris; Adolescent; Androgen Antagonists; Cross-Over Studies; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Hirsutism; Humans; Hyperandrogenism; Luteinizing Hormone; Medroxyprogesterone Acetate; Polycystic Ovary Syndrome; Prospective Studies; Quality of Life; Severity of Illness Index; Testosterone; Young Adult | 2014 |
Comparison of two oral contraceptive forms containing cyproterone acetate and drospirenone in the treatment of patients with polycystic ovary syndrome: a randomized clinical trial.
Topics: Adolescent; Adult; Androgen Antagonists; Androgens; Androstenes; Biomarkers; Body Mass Index; Carbohydrate Metabolism; Contraceptives, Oral, Combined; Cyproterone Acetate; Estrogens; Ethinyl Estradiol; Female; Humans; Lipids; Mineralocorticoid Receptor Antagonists; Oxidative Stress; Polycystic Ovary Syndrome; Treatment Outcome; Turkey; Waist-Hip Ratio | 2014 |
Berberine and monacolin effects on the cardiovascular risk profile of women with oestroprogestin-induced hypercholesterolemia.
Topics: Adult; Anticholesteremic Agents; Berberine; Cardiovascular Diseases; Contraception; Contraceptives, Oral; Dietary Supplements; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hypercholesterolemia; Lipid Metabolism; Lovastatin; Norpregnenes; Pilot Projects; Polycystic Ovary Syndrome; Prospective Studies; Risk Factors; Treatment Outcome | 2014 |
Body composition is improved during 12 months' treatment with metformin alone or combined with oral contraceptives compared with treatment with oral contraceptives in polycystic ovary syndrome.
Topics: Adolescent; Adult; Body Composition; Contraceptives, Oral, Combined; Desogestrel; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Metformin; Polycystic Ovary Syndrome; Treatment Outcome; Young Adult | 2014 |
Adiponectin, interleukin-6, monocyte chemoattractant protein-1, and regional fat mass during 12-month randomized treatment with metformin and/or oral contraceptives in polycystic ovary syndrome.
Topics: Abdominal Fat; Absorptiometry, Photon; Adiponectin; Adiposity; Adolescent; Adult; Body Mass Index; Chemokine CCL2; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Interleukin-6; Metformin; Obesity, Abdominal; Patient Dropouts; Polycystic Ovary Syndrome; Weight Gain; Whole Body Imaging; Young Adult | 2014 |
Comparison of desogestrel/ethinyl estradiol plus spironolactone versus cyproterone acetate/ethinyl estradiol in the treatment of polycystic ovary syndrome: a randomized controlled trial.
Topics: Acne Vulgaris; Adult; Androgen Antagonists; Androgens; Androstenedione; Cholesterol; Contraceptives, Oral, Synthetic; Cyproterone Acetate; Desogestrel; Drug Therapy, Combination; Estrogens; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Lipoproteins, HDL; Mineralocorticoid Receptor Antagonists; Polycystic Ovary Syndrome; Severity of Illness Index; Sex Hormone-Binding Globulin; Spironolactone; Young Adult | 2015 |
Comparison of the effects of chlormadinone acetate versus drospirenone containing oral contraceptives on metabolic and hormonal parameters in women with PCOS for a period of two-year follow-up.
Topics: Adult; Androstenes; Blood Glucose; Blood Pressure; C-Reactive Protein; Chlormadinone Acetate; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Follow-Up Studies; Humans; Insulin Resistance; Longitudinal Studies; Luteinizing Hormone; Polycystic Ovary Syndrome; Treatment Outcome; Triglycerides; Waist-Hip Ratio; Young Adult | 2015 |
Metformin improves endothelial function and carotid intima media thickness in patients with PCOS.
Topics: Adolescent; Adult; Androstenes; Brachial Artery; Carotid Arteries; Carotid Intima-Media Thickness; Contraceptives, Oral, Combined; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Metformin; Polycystic Ovary Syndrome; Treatment Outcome; Vasodilation; Young Adult | 2015 |
[Efficacy comparison between electroacupuncture and dyne-35 in treatment of polycystic ovary syndrome].
Topics: Acupuncture Points; Adolescent; Adult; Cyproterone Acetate; Drug Combinations; Electroacupuncture; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Polycystic Ovary Syndrome; Young Adult | 2014 |
Increased thrombin generation in women with polycystic ovary syndrome: A pilot study on the effect of metformin and oral contraceptives.
Topics: Adolescent; Adult; C-Reactive Protein; Contraceptives, Oral; Desogestrel; Ethinyl Estradiol; Female; Humans; Metformin; Pilot Projects; Polycystic Ovary Syndrome; Thrombin; Up-Regulation; Young Adult | 2015 |
A randomized controlled trial evaluating the effect of ethinyl estradiol during clomiphene citrate cycles among women with polycystic ovary syndrome.
Topics: Adult; Amenorrhea; Clomiphene; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Estrogens; Ethinyl Estradiol; Female; Fertility Agents, Female; Humans; Infertility, Female; Insemination, Artificial; Iran; Oligomenorrhea; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Rate | 2015 |
Comparison of two contraceptive pills containing drospirenone and 20 μg or 30 μg ethinyl estradiol for polycystic ovary syndrome.
Topics: Adult; Androgen Antagonists; Androgens; Androstenes; Contraceptives, Oral, Combined; Estrogens; Ethinyl Estradiol; Female; Humans; India; Mineralocorticoid Receptor Antagonists; Polycystic Ovary Syndrome; Young Adult | 2016 |
Oral contraceptives versus physical exercise on cardiovascular and metabolic risk factors in women with polycystic ovary syndrome: a randomized controlled trial.
Topics: Adult; Androstenes; Cardiovascular Diseases; Carotid Intima-Media Thickness; Contraceptives, Oral; Ethinyl Estradiol; Exercise; Female; Humans; Hyperandrogenism; Metabolic Diseases; Polycystic Ovary Syndrome; Risk Factors; Young Adult | 2016 |
Effects of metformin versus ethinyl-estradiol plus cyproterone acetate on ambulatory blood pressure monitoring and carotid intima media thickness in women with the polycystic ovary syndrome.
Topics: Adult; Androgen Antagonists; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Carotid Arteries; Cyproterone Acetate; Estrogens; Ethinyl Estradiol; Female; Humans; Hypertension; Hypoglycemic Agents; Metformin; Polycystic Ovary Syndrome; Tunica Intima; Young Adult | 2009 |
Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome.
Topics: Adult; Contraceptives, Oral, Combined; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Fasting; Female; Follicle Stimulating Hormone; Humans; Hyperandrogenism; Insulin; Luteinizing Hormone; Metformin; Obesity; Polycystic Ovary Syndrome; Prospective Studies; Testosterone; Waist-Hip Ratio | 2008 |
Clinical and metabolic effects of medroxyprogesterone acetate and ethinyl estradiol plus drospirenone in women with polycystic ovary syndrome.
Topics: Adolescent; Adult; Androgens; Androstenes; Carbohydrate Metabolism; Cholesterol; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Lipid Metabolism; Luteinizing Hormone; Medroxyprogesterone Acetate; Menstrual Cycle; Polycystic Ovary Syndrome; Testosterone; Young Adult | 2008 |
Endothelial function and insulin resistance in polycystic ovary syndrome: the effects of medical therapy.
Topics: Adult; Arginine; Biomarkers; Blood Glucose; C-Reactive Protein; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Drug Therapy, Combination; Endothelium, Vascular; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Hypoglycemic Agents; Inflammation Mediators; Insulin; Insulin Resistance; Lipids; Metformin; Plasminogen Activator Inhibitor 1; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Testosterone; Time Factors; Treatment Outcome; Vasodilation; von Willebrand Factor | 2010 |
Effects of an antiandrogenic oral contraceptive pill compared with metformin on blood coagulation tests and endothelial function in women with the polycystic ovary syndrome: influence of obesity and smoking.
Topics: Adult; Androgen Antagonists; Blood Coagulation; Blood Platelets; Case-Control Studies; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Drug Combinations; Endothelium, Vascular; Ethinyl Estradiol; Female; Fibrinogen; Homocysteine; Humans; Hypoglycemic Agents; Metformin; Obesity; Partial Thromboplastin Time; Polycystic Ovary Syndrome; Prothrombin; Smoking; Young Adult | 2009 |
Comparison of four different treatment regimens on coagulation parameters, hormonal and metabolic changes in women with polycystic ovary syndrome.
Topics: Adult; Blood Coagulation; Cyproterone Acetate; Estrogens; Ethinyl Estradiol; Female; Fibrin Fibrinogen Degradation Products; Hormones; Humans; Hypoglycemic Agents; Insulin Resistance; Lipids; Metformin; Mineralocorticoid Receptor Antagonists; Polycystic Ovary Syndrome; Spironolactone; Weight Loss; Young Adult | 2010 |
Polycystic ovary syndrome and cardiovascular risk in young patients treated with drospirenone-ethinylestradiol or contraceptive vaginal ring. A prospective, randomized, pilot study.
Topics: Adult; Androstenes; Blood Pressure; Brachial Artery; Cardiovascular Diseases; Cardiovascular Physiological Phenomena; Contraception; Contraceptive Devices, Female; Ethinyl Estradiol; Female; Humans; Insulin; Ovary; Pilot Projects; Polycystic Ovary Syndrome; Regional Blood Flow; Risk Factors; Ultrasonography; Young Adult | 2010 |
The effect of ethinylestradiol (EE)/cyproterone acetate (CA) and EE/CA plus metformin treatment on adhesion molecules in cases with polycystic ovary syndrome (PCOS).
Topics: Adult; Antineoplastic Agents; Cell Adhesion Molecules; Cyproterone Acetate; Drug Therapy, Combination; Estradiol; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Metformin; Polycystic Ovary Syndrome; Young Adult | 2009 |
Oral contraceptives alone and with spironolactone increase sCD40 ligand in PCOS patients.
Topics: Adolescent; Adult; CD40 Antigens; Contraceptives, Oral, Combined; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Mineralocorticoid Receptor Antagonists; Polycystic Ovary Syndrome; Spironolactone; Young Adult | 2010 |
Comparison of effects of 3 mg drospirenone plus 20 μg ethinyl estradiol alone or combined with metformin or cyproterone acetate on classic metabolic cardiovascular risk factors in nonobese women with polycystic ovary syndrome.
Topics: Administration, Oral; Adolescent; Adult; Androgens; Androstenes; Blood Pressure; Cardiovascular Diseases; Cyproterone; Dose-Response Relationship, Drug; Drug Therapy, Combination; Estrogens; Ethinyl Estradiol; Female; Glucose; Humans; Hypoglycemic Agents; Insulin; Lipids; Metformin; Mineralocorticoid Receptor Antagonists; Polycystic Ovary Syndrome; Risk Factors; Young Adult | 2010 |
Low-dose pioglitazone, flutamide, metformin plus an estro-progestagen for non-obese young women with polycystic ovary syndrome: increasing efficacy and persistent safety over 30 months.
Topics: Adolescent; Alanine Transaminase; Androgens; Androstenes; Aspartate Aminotransferases; Blood Glucose; Body Composition; C-Reactive Protein; Cholesterol; Cross-Over Studies; Drug Therapy, Combination; Ethinyl Estradiol; Female; Flutamide; gamma-Glutamyltransferase; Humans; Hydro-Lyases; Insulin; Longitudinal Studies; Metformin; Pioglitazone; Polycystic Ovary Syndrome; Thiazolidinediones; Tunica Intima; Young Adult | 2010 |
Metformin plus oral contraceptive may decrease plasma sCD40 ligand in women with PCOS patients.
Topics: Adult; Androgen Antagonists; Body Mass Index; CD40 Antigens; Contraceptives, Oral; Cyproterone Acetate; Dose-Response Relationship, Drug; Down-Regulation; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Insulin Resistance; Metformin; Polycystic Ovary Syndrome; Young Adult | 2011 |
Ethinylestradiol-chlormadinone acetate combination for the treatment of hirsutism and hormonal alterations of normal-weight women with polycystic ovary syndrome: evaluation of the metabolic impact.
Topics: Adolescent; Adult; Blood Glucose; Chlormadinone Acetate; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Glucose Clamp Technique; Glucose Tolerance Test; Hirsutism; Humans; Lipids; Polycystic Ovary Syndrome; Young Adult | 2010 |
L-arginine plus drospirenone-ethinyl estradiol in the treatment of patients with PCOS: a prospective, placebo controlled, randomised, pilot study.
Topics: Adult; Androstenedione; Androstenes; Arginine; Blood Flow Velocity; Brachial Artery; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Ovary; Pilot Projects; Polycystic Ovary Syndrome; Prospective Studies; Sex Hormone-Binding Globulin; Testosterone; Ultrasonography, Doppler, Color; Uterus; Young Adult | 2010 |
Effect of oral contraceptive containing ethinyl estradiol combined with drospirenone vs. desogestrel on clinical and biochemical parameters in patients with polycystic ovary syndrome.
Topics: Acne Vulgaris; Adolescent; Adult; Androstenes; Anthropometry; Blood Glucose; Blood Pressure; Contraceptives, Oral, Combined; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Hirsutism; Humans; Insulin; Lipoproteins, HDL; Lipoproteins, LDL; Polycystic Ovary Syndrome; Prospective Studies; Statistics, Nonparametric; Testosterone; Triglycerides; Young Adult | 2010 |
Effect of oral contraceptives on markers of hyperandrogenism and SHBG in women with polycystic ovary syndrome.
Topics: Adolescent; Adult; Androstenedione; Androstenes; Chlormadinone Acetate; Contraceptives, Oral, Combined; Dehydroepiandrosterone Sulfate; Desogestrel; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Norpregnenes; Polycystic Ovary Syndrome; Progesterone Congeners; Sex Hormone-Binding Globulin; Statistics, Nonparametric; Testosterone; Young Adult | 2010 |
The impact of oral contraceptives and metformin on anti-Müllerian hormone serum levels in women with polycystic ovary syndrome and biochemical hyperandrogenemia.
Topics: Adolescent; Adult; Androgen Antagonists; Androstenes; Anti-Mullerian Hormone; Blood Glucose; Body Mass Index; Cohort Studies; Contraceptives, Oral, Combined; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Hypoglycemic Agents; Insulin Resistance; Metformin; Polycystic Ovary Syndrome; Practice Guidelines as Topic; Young Adult | 2011 |
Drospirenone/ethinyl estradiol versus rosiglitazone treatment in overweight adolescents with polycystic ovary syndrome: comparison of metabolic, hormonal, and cardiovascular risk factors.
Topics: Adolescent; Adrenocorticotropic Hormone; Androstenes; Body Composition; Cardiovascular Diseases; Double-Blind Method; Ethinyl Estradiol; Female; Glucose Clamp Technique; Glucose Tolerance Test; Hemodynamics; Hormones; Humans; Hyperandrogenism; Hypoglycemic Agents; Insulin Resistance; Menstrual Cycle; Mineralocorticoid Receptor Antagonists; Overweight; Polycystic Ovary Syndrome; Risk Factors; Rosiglitazone; Stimulation, Chemical; Thiazolidinediones | 2011 |
Effect of ethinylestradiol/cyproterone acetate on endothelial function in young non-obese women with polycystic ovary syndrome: a pilot study.
Topics: Adolescent; Adult; Androgen Antagonists; Cyproterone Acetate; Drug Therapy, Combination; Estrogens; Ethinyl Estradiol; Female; Humans; Pilot Projects; Polycystic Ovary Syndrome; Prospective Studies; Regression Analysis; Vasodilation; Young Adult | 2011 |
[Hormonal treatment effectivity in hyperandrogenic syndrome].
Topics: Adult; Androgen Antagonists; Androstenes; Cyproterone Acetate; Estrogens; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Polycystic Ovary Syndrome; Syndrome | 2010 |
Increased plasma viscosity in young women with polycystic ovary syndrome using an oral contraceptive containing 35 μg ethinyl estradiol and 2 mg cyproterone acetate.
Topics: Adolescent; Adult; Blood Viscosity; Body Mass Index; Chemistry, Pharmaceutical; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Fibrinogen; Humans; Polycystic Ovary Syndrome; Triglycerides; Young Adult | 2011 |
Effect of combined metformin and oral contraceptive therapy on metabolic factors and endothelial function in overweight and obese women with polycystic ovary syndrome.
Topics: Analysis of Variance; Biomarkers; Blood Glucose; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Endothelium, Vascular; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Humans; Hypoglycemic Agents; Inflammation Mediators; Insulin; Insulin Resistance; Lipids; Metformin; Norgestrel; Obesity; Overweight; Placebo Effect; Polycystic Ovary Syndrome; Time Factors; Treatment Outcome; Vasodilation; Virginia | 2011 |
Efficacy of Chinese patent medicine Tian Gui Capsule in patients with polycystic ovary syndrome: a randomized controlled trial.
Topics: Adolescent; Adult; Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Drugs, Chinese Herbal; Ethinyl Estradiol; Female; Humans; Metformin; Phytotherapy; Polycystic Ovary Syndrome; Young Adult | 2011 |
Effects of ethinyl estradiol and desogestrel on clinical and metabolic parameters in Indian patients with polycystic ovary syndrome.
Topics: Acne Vulgaris; Adolescent; Adult; Blood Glucose; Body Composition; Body Mass Index; Desogestrel; Estrogens; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; India; Insulin; Insulin Resistance; Polycystic Ovary Syndrome; Progestins; Prospective Studies; Sex Hormone-Binding Globulin; Testosterone; Treatment Outcome | 2012 |
17-Hydroxysteroid dehydrogenase type 5 gene polymorphism (-71A/G HSD17B5 SNP) and treatment with oral contraceptive pills in PCOS women without metabolic comorbidities.
Topics: 3-Hydroxysteroid Dehydrogenases; Adolescent; Adult; Aldo-Keto Reductase Family 1 Member C3; Brazil; Contraceptives, Oral, Combined; Drug Therapy, Combination; Ethinyl Estradiol; Female; Genetic Association Studies; Hirsutism; Humans; Hydroxyprostaglandin Dehydrogenases; Hyperandrogenism; Mineralocorticoid Receptor Antagonists; Norpregnenes; Pilot Projects; Polycystic Ovary Syndrome; Polymorphism, Single Nucleotide; Severity of Illness Index; Sex Hormone-Binding Globulin; Spironolactone; Testosterone; Young Adult | 2012 |
The effects of 2 mg chlormadinone acetate/30 mcg ethinylestradiol, alone or combined with spironolactone, on cardiovascular risk markers in women with polycystic ovary syndrome.
Topics: Adult; Blood Glucose; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Carotid Arteries; Carotid Intima-Media Thickness; Chlormadinone Acetate; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Insulin; Mineralocorticoid Receptor Antagonists; Polycystic Ovary Syndrome; Risk Factors; Sex Hormone-Binding Globulin; Spironolactone; Testosterone; Triglycerides; Vasodilation | 2012 |
IVF/ICSI outcomes of the OCP plus GnRH agonist protocol versus the OCP plus GnRH antagonist fixed protocol in women with PCOS: a randomized trial.
Topics: Adult; Androstenes; Clinical Protocols; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Gonadotropin-Releasing Hormone; Humans; Infertility, Female; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Rate; Sperm Injections, Intracytoplasmic; Young Adult | 2012 |
The effects of drospirenone-ethinyl estradiol and drospirenone-ethinyl estradiol + metformin on ovarian ultrasonographic markers, body fat mass index, leptin, and ghrelin.
Topics: Abdominal Fat; Adiposity; Adolescent; Adult; Androstenes; Body Mass Index; Drug Therapy, Combination; Ethinyl Estradiol; Female; Ghrelin; Humans; Leptin; Metformin; Organ Size; Ovarian Follicle; Ovary; Polycystic Ovary Syndrome; Reproductive Control Agents; Ultrasonography; Young Adult | 2013 |
[Ultrasonographic and lipid changes in polycystic ovary syndrome according to the type of treatment ].
Topics: Adult; Chlormadinone Acetate; Cholesterol; Desogestrel; Drug Therapy, Combination; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Ovarian Follicle; Polycystic Ovary Syndrome; Progesterone Congeners; Severity of Illness Index; Treatment Outcome; Triglycerides; Ultrasonography | 2002 |
Metformin versus ethinyl estradiol-cyproterone acetate in the treatment of nonobese women with polycystic ovary syndrome: a randomized study.
Topics: Adult; Contraceptives, Oral; Cyproterone Acetate; Drug Combinations; Energy Metabolism; Estradiol Congeners; Ethinyl Estradiol; Fatty Acids, Nonesterified; Female; Hormones; Humans; Hypoglycemic Agents; Lipid Metabolism; Lipids; Metformin; Oxidation-Reduction; Polycystic Ovary Syndrome | 2003 |
Leptin levels in patients with polycystic ovary syndrome in response to two different oral contraceptive treatments.
Topics: Administration, Oral; Adult; Androgen Antagonists; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Cyproterone Acetate; Desogestrel; Drug Combinations; Estradiol Congeners; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Humans; Leptin; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Steroids | 2003 |
Glucose metabolism and insulin resistance in women with polycystic ovary syndrome during therapy with oral contraceptives containing cyproterone acetate or desogestrel.
Topics: Adult; Anthropometry; Blood Glucose; Body Weight; C-Peptide; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Desogestrel; Ethinyl Estradiol; Female; Glucose; Glucose Tolerance Test; Hormones; Humans; Insulin; Insulin Resistance; Polycystic Ovary Syndrome | 2003 |
Metformin or antiandrogen in the treatment of hirsutism in polycystic ovary syndrome.
Topics: Acne Vulgaris; Androgen Antagonists; Anthropometry; Blood Glucose; Blood Pressure; Body Mass Index; Cyproterone Acetate; Estradiol Congeners; Ethinyl Estradiol; Female; Hirsutism; Hormones; Humans; Hypoglycemic Agents; Insulin Resistance; Lipids; Metformin; Polycystic Ovary Syndrome; Sebum | 2003 |
Metformin reduces serum C-reactive protein levels in women with polycystic ovary syndrome.
Topics: Adult; C-Reactive Protein; Cyproterone Acetate; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Metformin; Obesity; Polycystic Ovary Syndrome; Progesterone Congeners | 2003 |
Sibutramine has a positive effect on clinical and metabolic parameters in obese patients with polycystic ovary syndrome.
Topics: Adult; Androgen Antagonists; Appetite Depressants; Blood Pressure; Body Constitution; Body Weight; Cyclobutanes; Cyproterone Acetate; Diastole; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Hirsutism; Hormones; Humans; Obesity; Polycystic Ovary Syndrome; Treatment Outcome; Triglycerides | 2003 |
Ethinylestradiol-drospirenone, flutamide-metformin, or both for adolescents and women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity.
Topics: Adiponectin; Adipose Tissue; Adolescent; Adult; Androgen Antagonists; Androstenes; Drug Therapy, Combination; Estrogens; Ethinyl Estradiol; Female; Flutamide; Hormone Antagonists; Humans; Hyperandrogenism; Hyperinsulinism; Hypoglycemic Agents; Intercellular Signaling Peptides and Proteins; Interleukin-6; Metformin; Mineralocorticoid Receptor Antagonists; Polycystic Ovary Syndrome; Proteins | 2004 |
Drospirenone for the treatment of hirsute women with polycystic ovary syndrome: a clinical, endocrinological, metabolic pilot study.
Topics: Adult; Androstenes; Blood Pressure; Cholesterol, HDL; Cholesterol, LDL; Drug Therapy, Combination; Estrogens; Ethinyl Estradiol; Female; Hirsutism; Humans; Middle Aged; Mineralocorticoid Receptor Antagonists; Pilot Projects; Polycystic Ovary Syndrome; Treatment Outcome; Triglycerides | 2004 |
Flutamide-metformin plus an oral contraceptive (OC) for young women with polycystic ovary syndrome: switch from third- to fourth-generation OC reduces body adiposity.
Topics: Abdomen; Adipose Tissue; Adolescent; Adult; Androgen Antagonists; Contraceptives, Oral; Drug Therapy, Combination; Estrogens; Ethinyl Estradiol; Female; Flutamide; Humans; Hypoglycemic Agents; Metformin; Norpregnenes; Obesity; Polycystic Ovary Syndrome | 2004 |
Ovarian stimulation by concomitant administration of cetrorelix acetate and HMG following Diane-35 pre-treatment for patients with polycystic ovary syndrome: a prospective randomized study.
Topics: Adult; Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Hormone Antagonists; Hormones; Humans; Incidence; Infertility, Female; Menotropins; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Pilot Projects; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Outcome; Pregnancy Rate; Premedication | 2004 |
[Combined use of metformin and Diane35 in polycystic ovary syndrome].
Topics: Administration, Oral; Adolescent; Adult; Androgen Antagonists; Cyproterone Acetate; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Metformin; Polycystic Ovary Syndrome; Prospective Studies; Treatment Outcome | 2004 |
Flutamide-metformin plus ethinylestradiol-drospirenone for lipolysis and antiatherogenesis in young women with ovarian hyperandrogenism: the key role of early, low-dose flutamide.
Topics: Adiponectin; Adolescent; Androstenes; Arteriosclerosis; Drug Therapy, Combination; Ethinyl Estradiol; Female; Flutamide; Humans; Hyperandrogenism; Intercellular Signaling Peptides and Proteins; Interleukin-6; Lipolysis; Metformin; Polycystic Ovary Syndrome; Proteins | 2004 |
Finasteride versus cyproterone acetate-estrogen regimens in the treatment of hirsutism.
Topics: Adolescent; Adult; Androgen Antagonists; Cyproterone Acetate; Enzyme Inhibitors; Ethinyl Estradiol; Female; Finasteride; Hirsutism; Humans; Polycystic Ovary Syndrome; Prospective Studies | 2004 |
Flutamide-metformin plus ethinylestradiol-drospirenone for lipolysis and antiatherogenesis in young women with ovarian hyperandrogenism: the key role of metformin at the start and after more than one year of therapy.
Topics: Adolescent; Adult; Androstenes; Arteriosclerosis; Drug Therapy, Combination; Ethinyl Estradiol; Female; Flutamide; Humans; Hyperandrogenism; Lipolysis; Metformin; Polycystic Ovary Syndrome; Time Factors | 2005 |
Combined use of metformin and ethinyl estradiol-cyproterone acetate in polycystic ovary syndrome.
Topics: Adult; Androgen Antagonists; Body Mass Index; Cyproterone Acetate; Dehydroepiandrosterone Sulfate; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Metformin; Polycystic Ovary Syndrome; Prospective Studies; Sex Hormone-Binding Globulin; Testosterone; Waist-Hip Ratio | 2005 |
Ethinylestradiol/cyproterone acetate in polycystic ovary syndrome: lipid and carbohydrate changes.
Topics: Administration, Oral; Adult; Androgens; Blood Glucose; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cyproterone Acetate; Drug Administration Schedule; Ethinyl Estradiol; Female; Humans; Polycystic Ovary Syndrome; Prospective Studies; Sex Hormone-Binding Globulin; Treatment Outcome; Triglycerides | 2004 |
Effects of metformin and ethinyl estradiol-cyproterone acetate on lipid levels in obese and non-obese women with polycystic ovary syndrome.
Topics: Adult; Androgen Antagonists; Cardiovascular Diseases; Cholesterol; Cyproterone Acetate; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Metformin; Obesity; Polycystic Ovary Syndrome; Treatment Outcome | 2005 |
Rosiglitazone and ethinyl estradiol/cyproterone acetate as single and combined treatment of overweight women with polycystic ovary syndrome and insulin resistance.
Topics: Adolescent; Adult; Androgens; Blood Glucose; Cholesterol, HDL; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Hirsutism; Humans; Insulin; Insulin Resistance; Middle Aged; Obesity; Polycystic Ovary Syndrome; Rosiglitazone; Thiazolidinediones | 2006 |
[Clinical research on combined therapy of diane-35 with modified yougui pill on polycystic ovarian syndrome].
Topics: Adult; Androgen Antagonists; Cyproterone Acetate; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Drugs, Chinese Herbal; Ethinyl Estradiol; Female; Humans; Phytotherapy; Polycystic Ovary Syndrome; Tablets | 2005 |
Comparison of the clinical efficacy of flutamide and spironolactone plus Diane 35 in the treatment of idiopathic hirsutism: a randomized controlled study.
Topics: Adult; Androgen Antagonists; Cyproterone Acetate; Diuretics; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Flutamide; Hirsutism; Humans; Polycystic Ovary Syndrome; Prospective Studies; Spironolactone; Treatment Outcome | 2005 |
Effects of two different oral contraceptives on homocysteine metabolism in women with polycystic ovary syndrome.
Topics: Adult; Blood Glucose; Contraceptives, Oral; Cyproterone Acetate; Desogestrel; Ethinyl Estradiol; Female; Folic Acid; Homocysteine; Humans; Insulin; Insulin Resistance; Polycystic Ovary Syndrome; Vitamin B 12 | 2006 |
Effects of simvastatin and oral contraceptive agent on polycystic ovary syndrome: prospective, randomized, crossover trial.
Topics: Adult; Contraceptives, Oral, Combined; Cross-Over Studies; Desogestrel; Drug Therapy, Combination; Estrogens; Ethinyl Estradiol; Female; Humans; Hypolipidemic Agents; Pituitary Hormones; Polycystic Ovary Syndrome; Prospective Studies; Simvastatin; Testosterone; Treatment Outcome | 2007 |
Plasma ghrelin concentrations in patients with polycystic ovary syndrome before and after 6months therapy: correlation with androgen levels.
Topics: Adult; Androgen Antagonists; Androgens; Androstenedione; Cyproterone Acetate; Dehydroepiandrosterone; Drug Combinations; Ethinyl Estradiol; Female; Ghrelin; Humans; Peptide Hormones; Polycystic Ovary Syndrome; Testosterone | 2006 |
Weight change and androgen levels during contraceptive treatment of women affected by polycystic ovary.
Topics: Adult; Androgens; Body Weight; Contraception; Contraceptives, Oral, Combined; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Lipids; Polycystic Ovary Syndrome; Weight Gain | 2006 |
Effects of the pharmacologic manipulation of testosterone on cognitive functioning in women with polycystic ovary syndrome: a randomized, placebo-controlled treatment study.
Topics: Adult; Analysis of Variance; Cognition; Cyproterone; Double-Blind Method; Ethinyl Estradiol; Female; Hormones; Humans; Motor Skills; Neuropsychological Tests; Polycystic Ovary Syndrome; Space Perception; Testosterone; Verbal Behavior | 2007 |
The administration of estrogens, combined with anti-androgens, has beneficial effects on the hormonal features and asymmetric dimethyl-arginine levels, in women with the polycystic ovary syndrome.
Topics: Adult; Androgen Antagonists; Arginine; Cyproterone Acetate; Desogestrel; Drug Therapy, Combination; Endothelin-1; Estradiol; Estrogens; Estrogens, Conjugated (USP); Ethinyl Estradiol; Female; Hormones; Humans; Insulin Resistance; Polycystic Ovary Syndrome | 2008 |
Comparison of ethinyl-estradiol plus cyproterone acetate versus metformin effects on classic metabolic cardiovascular risk factors in women with the polycystic ovary syndrome.
Topics: Administration, Oral; Adult; Androgen Antagonists; Androgens; Blood Glucose; Cardiovascular Diseases; Cyproterone Acetate; Drug Combinations; Dyslipidemias; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Insulin Resistance; Lipids; Metformin; Polycystic Ovary Syndrome; Risk Factors | 2007 |
Efficacy of an oral contraceptive containing drospirenone in the treatment of women with polycystic ovary syndrome.
Topics: Adult; Androstenes; Blood Glucose; Body Mass Index; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Insulin; Polycystic Ovary Syndrome; Prospective Studies; Severity of Illness Index; Sex Hormone-Binding Globulin; Testosterone; Treatment Outcome | 2007 |
Increased body iron stores of obese women with polycystic ovary syndrome are a consequence of insulin resistance and hyperinsulinism and are not a result of reduced menstrual losses.
Topics: Adolescent; Adult; Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Ferritins; Humans; Hyperinsulinism; Hypoglycemic Agents; Insulin Resistance; Iron; Metformin; Obesity; Oligomenorrhea; Polycystic Ovary Syndrome | 2007 |
The effect of ethinyl estradiol-cyproterone acetate treatment on homocysteine levels in women with polycystic ovary syndrome.
Topics: Adult; Androgen Antagonists; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Follicular Phase; Homocysteine; Humans; Lipids; Obesity; Polycystic Ovary Syndrome; Prospective Studies; Testosterone | 2008 |
Serum uric acid concentration as non-classic cardiovascular risk factor in women with polycystic ovary syndrome: effect of treatment with ethinyl-estradiol plus cyproterone acetate versus metformin.
Topics: Adolescent; Adult; Body Mass Index; Cross-Sectional Studies; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Metformin; Obesity; Polycystic Ovary Syndrome; Risk Factors; Uric Acid | 2008 |
Treatment of hirsutism with combined pill containing drospirenone.
Topics: Administration, Oral; Adolescent; Adult; Androstenes; Drug Combinations; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Follow-Up Studies; Greece; Hirsutism; Humans; Luteinizing Hormone; Mineralocorticoid Receptor Antagonists; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Testosterone | 2008 |
Retinol-binding protein 4 and insulin resistance in polycystic ovary syndrome.
Topics: Adult; Body Mass Index; Contraceptives, Oral; Cyproterone; Ethinyl Estradiol; Female; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Insulin Resistance; Metformin; Overweight; Polycystic Ovary Syndrome; Retinol-Binding Proteins, Plasma; Waist-Hip Ratio | 2008 |
Effects of long-term administration of an oral contraceptive containing ethinylestradiol and cyproterone acetate on lipid metabolism in women with polycystic ovary syndrome.
Topics: Adult; Apoproteins; Cholesterol; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Lipid Metabolism; Lipoproteins; Polycystic Ovary Syndrome; Pregnancy; Testosterone; Triglycerides | 1995 |
Treatment of polycystic ovarian disease during adolescence with ethinylestradiol/cyproterone acetate versus a D-Tr-6-LHRH analog.
Topics: Adolescent; Androstenedione; Cyproterone Acetate; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Delayed-Action Preparations; Dinoprostone; Drug Therapy, Combination; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Polycystic Ovary Syndrome; Prolactin; Prospective Studies; Sex Hormone-Binding Globulin; Testosterone; Triptorelin Pamoate | 1993 |
Treatment of hirsutism with flutamide and a low-dosage oral contraceptive in polycystic ovarian disease patients.
Topics: Adolescent; Adult; Contraceptives, Oral; Desogestrel; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ethinyl Estradiol; Female; Flutamide; Gonadal Steroid Hormones; Hirsutism; Humans; Polycystic Ovary Syndrome; Treatment Outcome | 1994 |
Results of an open one-year study with Diane-35 in women with polycystic ovarian syndrome.
Topics: Adolescent; Adult; Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Drug Tolerance; Ethinyl Estradiol; Female; Humans; Polycystic Ovary Syndrome; Ultrasonography | 1993 |
Clinical and hormonal effects of the combination gonadotrophin-releasing hormone agonist plus oral contraceptive pills containing ethinyl-oestradiol (EE) and cyproterone acetate (CPA) versus the EE-CPA pill alone on polycystic ovarian disease-related hype
Topics: Adolescent; Adult; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Hirsutism; Hormones; Humans; Polycystic Ovary Syndrome; Treatment Outcome; Triptorelin Pamoate | 1997 |
Effects of two antiandrogen treatments on hirsutism and insulin sensitivity in women with polycystic ovary syndrome.
Topics: Adult; Androgen Antagonists; Androgens; Cyproterone Acetate; Estradiol Congeners; Ethinyl Estradiol; Female; Goserelin; Hirsutism; Humans; Insulin Resistance; Lipids; Polycystic Ovary Syndrome | 1998 |
Divergent effects of weight reduction and oral anticonception treatment on adrenergic lipolysis regulation in obese women with the polycystic ovary syndrome.
Topics: Adipocytes; Adipose Tissue; Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Sequential; Diet, Reducing; Estradiol Congeners; Estrogens; Ethinyl Estradiol; Female; Humans; Lipolysis; Norethindrone; Obesity; Polycystic Ovary Syndrome; Radioligand Assay; Sympathetic Nervous System; Weight Loss | 1999 |
Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism.
Topics: Adolescent; Adult; Androgen Antagonists; Androgens; Cyproterone Acetate; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Finasteride; Hirsutism; Humans; Polycystic Ovary Syndrome; Prospective Studies; Single-Blind Method; Treatment Outcome | 2000 |
Spironolactone as a single agent for long-term therapy of hirsute patients.
Topics: Adolescent; Adult; Androgen Antagonists; Androstenedione; Cyproterone Acetate; Drug Therapy, Combination; Estradiol Congeners; Ethinyl Estradiol; Female; Hirsutism; Humans; Luteinizing Hormone; Polycystic Ovary Syndrome; Prospective Studies; Spironolactone; Testosterone | 2000 |
Combined oral contraceptive treatment of adolescent girls with polycystic ovary syndrome. Lipid profile.
Topics: Adolescent; Contraceptives, Oral, Combined; Cyproterone Acetate; Desogestrel; Ethinyl Estradiol; Female; Humans; Lipids; Polycystic Ovary Syndrome | 2000 |
Endocrine and metabolic effects of metformin versus ethinyl estradiol-cyproterone acetate in obese women with polycystic ovary syndrome: a randomized study.
Topics: Adult; Androgen Antagonists; Area Under Curve; Blood Glucose; Calorimetry; Cyproterone Acetate; Estradiol Congeners; Ethinyl Estradiol; Fats; Female; Glucose Clamp Technique; Glucose Tolerance Test; Hormones; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Metformin; Obesity; Polycystic Ovary Syndrome | 2000 |
Long-term GnRH analogue treatment is equivalent to laparoscopic laser diathermy in polycystic ovarian syndrome patients with severe ovarian dysfunction.
Topics: Adult; Androgen Antagonists; Chorionic Gonadotropin; Clomiphene; Cyproterone Acetate; Drug Combinations; Electrocoagulation; Ethinyl Estradiol; Female; Fertility Agents, Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Infertility, Female; Laparoscopy; Lasers; Leuprolide; Ovary; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Outcome; Prospective Studies; Recombinant Proteins | 2000 |
Hormonal and clinical effects of GnRH agonist alone, or in combination with a combined oral contraceptive or flutamide in women with severe hirsutism.
Topics: Adult; Amenorrhea; Androgen Antagonists; Contraceptives, Oral, Combined; Cyproterone Acetate; Estradiol; Estradiol Congeners; Estrone; Ethinyl Estradiol; Female; Flutamide; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Hirsutism; Humans; Luteinizing Hormone; Luteolytic Agents; Polycystic Ovary Syndrome; Progesterone Congeners; Prospective Studies; Triptorelin Pamoate | 2000 |
Androgen and lipid profiles in adolescents with polycystic ovary syndrome who were treated with two forms of combined oral contraceptives.
Topics: Adolescent; Adult; Androgen Antagonists; Androgens; Apolipoprotein A-I; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Cyproterone Acetate; Desogestrel; Estrogens; Ethinyl Estradiol; Female; Hirsutism; Humans; Lipids; Polycystic Ovary Syndrome; Severity of Illness Index; Triglycerides | 2002 |
Clinical, endocrine and metabolic effects of metformin added to ethinyl estradiol-cyproterone acetate in non-obese women with polycystic ovarian syndrome: a randomized controlled study.
Topics: Adolescent; Adult; Androstenedione; Body Constitution; Body Mass Index; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Insulin Resistance; Metformin; Polycystic Ovary Syndrome; Prospective Studies; Sex Hormone-Binding Globulin | 2002 |
[Anti-androgenic steroid cyproterone acetate. Clinical pharmacology and therapeutic use in hirsutism and acne].
Topics: Acne Vulgaris; Adult; Aged; Androgen Antagonists; Clinical Trials as Topic; Cyproterone; Ethinyl Estradiol; Female; Hirsutism; Humans; Male; Middle Aged; Nitrogen; Polycystic Ovary Syndrome | 1976 |
Effects of a low-dose desogestrel-ethinylestradiol combination on hirsutism, androgens and sex hormone binding globulin in women with a polycystic ovary syndrome.
Topics: Adult; Androstenedione; Body Weight; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Hirsutism; Humans; Luteinizing Hormone; Middle Aged; Norpregnenes; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Testosterone | 1985 |
Lipid metabolic studies in women with a polycystic ovary syndrome during treatment with a low-dose desogestrel-ethinylestradiol combination.
Topics: Adult; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Lipids; Lipoproteins; Middle Aged; Norpregnenes; Polycystic Ovary Syndrome | 1985 |
115 other study(ies) available for ethinyl estradiol and Polycystic Ovary Syndrome
| Article | Year |
|---|---|
Diane-35 and Metformin Induce Autophagy and Apoptosis in Polycystic Ovary Syndrome Women with Early-Stage Endometrial Carcinoma.
Topics: Androgen Antagonists; Animals; Apoptosis; Autophagy; Cyproterone Acetate; Drug Combinations; Drug Therapy, Combination; Endometrial Neoplasms; Ethinyl Estradiol; Female; Glucose Transporter Type 4; Hypoglycemic Agents; Insulin-Like Growth Factor I; Metformin; Mice; Polycystic Ovary Syndrome; Receptors, Androgen | 2022 |
Association between preconception anti-androgen therapy and pregnancy outcomes of patients with PCOS: A prospective cohort study.
Topics: Ethinyl Estradiol; Female; Humans; Infant, Newborn; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Outcome; Premature Birth; Prospective Studies | 2023 |
Effectiveness and safety assessment of drospirenone/ethinyl estradiol tablet in treatment of PCOS patients: a single center, prospective, observational study.
Topics: Adult; Androstenes; Body Mass Index; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Polycystic Ovary Syndrome; Prospective Studies; Reproductive Control Agents; Tablets; Testosterone; Treatment Outcome; Triglycerides; Young Adult | 2020 |
Combined use of Diane-35 and metformin improves the ovulation in the PCOS rat model possibly via regulating glycolysis pathway.
Topics: Androgen Antagonists; Animals; Apoptosis; Body Weight; Cyproterone Acetate; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Glycolysis; Hypoglycemic Agents; Insulin Resistance; Lactate Dehydrogenase 5; Luteinizing Hormone; Metformin; Ovary; Ovulation; Polycystic Ovary Syndrome; Pyruvate Kinase; Rats; Sirtuin 1; Testosterone | 2020 |
Metformin metabolic and vascular effects in normal weight hyperinsulinemic polycystic ovary syndrome patients treated with contraceptive vaginal ring. A pilot study.
Topics: Adult; Blood Glucose; Brachial Artery; Contraceptive Agents, Hormonal; Contraceptive Devices, Female; Desogestrel; Ethinyl Estradiol; Female; Glucose Tolerance Test; Humans; Hyperinsulinism; Hypoglycemic Agents; Insulin Resistance; Longitudinal Studies; Metformin; Ophthalmic Artery; Pilot Projects; Polycystic Ovary Syndrome; Retrospective Studies; Ultrasonography, Doppler; Vasodilation; Young Adult | 2020 |
An Unusual Case of Right Flank Pain.
Topics: Adolescent; Androstenes; Ethinyl Estradiol; Female; Flank Pain; Humans; Infarction; Kidney; Polycystic Ovary Syndrome | 2021 |
Treatment of hyperandrogenism in women with ethinylestradiol and cyproteroneacetate.
Topics: Androgen Antagonists; Cyproterone Acetate; Estrogens; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Polycystic Ovary Syndrome | 2017 |
Hypercupremia secondary to oral contraceptives: report of 2 cases.
Topics: Ceruloplasmin; Contraceptives, Oral; Copper; Crohn Disease; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Malnutrition; Oligonucleotides; Polycystic Ovary Syndrome; Spectrophotometry, Atomic; Young Adult; Zinc | 2017 |
Effect of orlistat or metformin in overweight and obese polycystic ovary syndrome patients with insulin resistance.
Topics: Adult; Anti-Obesity Agents; Cyproterone Acetate; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Insulin Resistance; Lactones; Metformin; Obesity; Orlistat; Overweight; Polycystic Ovary Syndrome; Young Adult | 2018 |
Comparing the risk of adverse pregnancy outcomes of Chinese patients with polycystic ovary syndrome with and without antiandrogenic pretreatment.
Topics: Adult; Androgen Antagonists; Birth Weight; China; Clomiphene; Cyproterone Acetate; Diabetes, Gestational; Drug Combinations; Ethinyl Estradiol; Female; Fertility Agents, Female; Humans; Hypertension, Pregnancy-Induced; Infant, Newborn; Infertility, Female; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Complications; Premature Birth; Prevalence; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Time-to-Pregnancy; Treatment Outcome; Young Adult | 2018 |
Association between CD16
Topics: Adult; Biomarkers; Case-Control Studies; China; Cross-Sectional Studies; Cyproterone Acetate; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Insulin Resistance; Metformin; Monocytes; Polycystic Ovary Syndrome; Prospective Studies; Receptors, IgG | 2019 |
Oral contraceptive use increases risk of inflammatory and coagulatory disorders in women with Polycystic Ovarian Syndrome: An observational study.
Topics: Adult; Body Mass Index; Coagulation Protein Disorders; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; India; Inflammation; Insulin; Insulin Resistance; Levonorgestrel; Metformin; Polycystic Ovary Syndrome; Risk Factors; Waist-Hip Ratio; Young Adult | 2019 |
Clinical efficacy of low dose flutamide plus Diane-35 in the treatment of idiopathic hirsutism and polycystic ovary syndrome.
Topics: Adult; Androgen Antagonists; Cyproterone Acetate; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Flutamide; Hirsutism; Humans; Polycystic Ovary Syndrome; Severity of Illness Index; Treatment Outcome; Women's Health; Young Adult | 2013 |
Effect of ethinyl estradiol-cyproterone acetate treatment on asymmetric dimethyl-arginine levels in women with polycystic ovary syndrome.
Topics: Adult; Androgen Antagonists; Arginine; Cholesterol, LDL; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Glucose; Humans; Insulin Resistance; Lipid Metabolism; Polycystic Ovary Syndrome; Prospective Studies; Young Adult | 2014 |
Basal and meal-stimulated ghrelin, PYY, CCK levels and satiety in lean women with polycystic ovary syndrome: effect of low-dose oral contraceptive.
Topics: Adolescent; Adult; Androstenes; Basal Metabolism; Body Weight; Cholecystokinin; Contraceptives, Oral; Eating; Estrogens; Ethinyl Estradiol; Female; Ghrelin; Humans; Mineralocorticoid Receptor Antagonists; Peptide YY; Polycystic Ovary Syndrome; Prospective Studies; Satiety Response; Young Adult | 2013 |
A macroprolactin level today may keep health care cost and the surgical knife at bay.
Topics: Adolescent; Amenorrhea; Desogestrel; Diagnosis, Differential; Estrogens; Ethinyl Estradiol; Female; Health Expenditures; Humans; Hyperprolactinemia; Polycystic Ovary Syndrome; Progestins; Prolactin | 2015 |
The platelet activating factor acetyl hydrolase, oxidized low-density lipoprotein, paraoxonase 1 and arylesterase levels in treated and untreated patients with polycystic ovary syndrome.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Adult; Androgen Antagonists; Aryldialkylphosphatase; Body Mass Index; Carboxylic Ester Hydrolases; Case-Control Studies; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Lipoproteins, LDL; Metformin; Phospholipase A2 Inhibitors; Platelet Activating Factor; Polycystic Ovary Syndrome; Polymorphism, Single Nucleotide; Treatment Outcome | 2014 |
The effect of drospirenone (3 mg) with ethinyl estradiol (30 mcg) containing pills on ovarian blood flows in women with polycystic ovary syndrome: a case controlled study.
Topics: Adult; Androstenes; Case-Control Studies; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Ovary; Polycystic Ovary Syndrome; Prospective Studies; Regional Blood Flow; Ultrasonography, Doppler, Color; Ultrasonography, Doppler, Pulsed; Young Adult | 2014 |
How medical treatment affects mean platelet volume as a cardiovascular risk marker in polycystic ovary syndrome?
Topics: Adolescent; Adult; Androgen Antagonists; Biomarkers; Blood Platelets; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Insulin Resistance; Leukocyte Count; Mean Platelet Volume; Metformin; Polycystic Ovary Syndrome; Regression Analysis; Treatment Outcome | 2015 |
Dual suppression with oral contraceptive pills in GnRH antagonist cycles for patients with polycystic ovary syndrome undergoing intracytoplasmic sperm injection.
Topics: Adult; Androstenes; Cohort Studies; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Drug Administration Schedule; Drug Therapy, Combination; Embryo Transfer; Ethinyl Estradiol; Female; Fertility Agents, Female; Gonadotropin-Releasing Hormone; Humans; Infertility, Female; Leuprolide; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Rate; Retrospective Studies; Sperm Injections, Intracytoplasmic; Treatment Outcome | 2014 |
Polycystic ovary syndrome (PCOS): metformin.
Topics: Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Metformin; Polycystic Ovary Syndrome; Weight Reduction Programs | 2015 |
Metabolic profile of Diane-35 versus Diane-35 plus metformin in Chinese PCOS women under standardized life-style changes.
Topics: Adolescent; Adult; Androgen Antagonists; China; Cyproterone Acetate; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Hypoglycemic Agents; Metabolome; Metformin; Polycystic Ovary Syndrome; Treatment Outcome; Young Adult | 2015 |
Exploring the significance of sex hormone-binding globulin examination in the treament of women with polycystic ovarian syndrome (PCOS).
Topics: Abortion, Spontaneous; Adult; Androgen Antagonists; Blood Glucose; Body Mass Index; Clomiphene; Cyproterone Acetate; Drug Combinations; Drug Therapy, Combination; Estradiol; Ethinyl Estradiol; Female; Fertility Agents, Female; Follicle Stimulating Hormone; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Live Birth; Luteinizing Hormone; Metformin; Obesity; Ovulation Induction; Polycystic Ovary Syndrome; Prolactin; Sex Hormone-Binding Globulin; Testosterone; Treatment Outcome; Young Adult | 2015 |
Evaluation of Apelin and Insulin Resistance in Patients with PCOS and Therapeutic Effect of Drospirenone-Ethinylestradiol Plus Metformin.
Topics: Adult; Androstenes; Apelin; Blood Glucose; Body Mass Index; Case-Control Studies; Drug Therapy, Combination; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Intercellular Signaling Peptides and Proteins; Metformin; Polycystic Ovary Syndrome; Reproductive Control Agents; Young Adult | 2015 |
Management of polycystic ovarian syndrome with Diane-35 or Diane-35 plus metformin.
Topics: Adult; Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Metformin; Outcome Assessment, Health Care; Polycystic Ovary Syndrome; Young Adult | 2016 |
Metabolic Effects of a Commonly Used Combined Hormonal Oral Contraceptive in Women With and Without Polycystic Ovary Syndrome.
Topics: Adult; Blood Glucose; Carbohydrates; Case-Control Studies; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Dose-Response Relationship, Drug; Estrogens; Ethinyl Estradiol; Female; Glucose Tolerance Test; Gonadal Steroid Hormones; Humans; Insulin; Lipid Metabolism; Lipids; Norgestrel; Polycystic Ovary Syndrome | 2016 |
[Changes of serum TOS and TAS levels and their association with apolipoprotein(a) in patients with polycystic ovary syndrome and infertility].
Topics: Antioxidants; Apoprotein(a); Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Infertility, Female; Oxidative Stress; Polycystic Ovary Syndrome | 2016 |
Does the Oral Contraceptive Pill Increase Plasma Intercellular Adhesion Molecule-1, Monocyte Chemoattractant Protein-1, and Tumor Necrosis Factor-α Levels in Women with Polycystic Ovary Syndrome: A Pilot Study.
Topics: Adolescent; Adult; Chemokine CCL2; Contraceptives, Oral, Combined; Cross-Sectional Studies; Drug Combinations; Ethinyl Estradiol; Female; Humans; Intercellular Adhesion Molecule-1; Levonorgestrel; Pilot Projects; Polycystic Ovary Syndrome; Tumor Necrosis Factor-alpha; Young Adult | 2017 |
Pills-related severe adverse events: A case report in Taiwan.
Topics: Androgen Antagonists; Body Mass Index; Contraceptives, Oral, Combined; Cyproterone; Estrogens; Ethinyl Estradiol; Female; Humans; Menstruation Disturbances; Overweight; Polycystic Ovary Syndrome; Taiwan; Thromboembolism; Young Adult | 2016 |
Prescribing of cyproterone acetate/ethinylestradiol in UK general practice: a retrospective descriptive study using The Health Improvement Network.
Topics: Acne Vulgaris; Adolescent; Adult; Androgen Antagonists; Contraceptives, Oral, Combined; Cyproterone Acetate; Databases, Factual; Drug Combinations; Ethinyl Estradiol; Female; General Practice; Hirsutism; Humans; Hyperandrogenism; Off-Label Use; Polycystic Ovary Syndrome; Retrospective Studies; United Kingdom; Young Adult | 2017 |
Restored Plasma Anandamide and Endometrial Expression of Fatty Acid Amide Hydrolase in Women With Polycystic Ovary Syndrome by the Combination Use of Diane-35 and Metformin.
Topics: Adult; Amidohydrolases; Androgen Antagonists; Arachidonic Acids; Cyproterone Acetate; Drug Combinations; Endocannabinoids; Endometrium; Ethinyl Estradiol; Female; Glycerides; Humans; Infertility, Female; Metformin; Polycystic Ovary Syndrome; Polyunsaturated Alkamides; Receptors, Cannabinoid; Young Adult | 2017 |
Confluent and reticulated papillomatosis associated with polycystic ovary syndrome treated with a combined contraceptive containing drospirenone.
Topics: Adult; Androstenes; Ethinyl Estradiol; Female; Humans; Papilloma; Polycystic Ovary Syndrome | 2009 |
Homeostasis model assessment-insulin resistance (HOMA-IR), a key role for assessing the ovulation function in polycystic ovary syndrome (PCOS) patients with insulin resistance.
Topics: Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Homeostasis; Humans; Hypoglycemic Agents; Insulin Resistance; Metformin; Models, Biological; Ovarian Follicle; Ovary; Ovulation; Polycystic Ovary Syndrome; Sensitivity and Specificity | 2008 |
[The effects of oxidative stress to PCOS].
Topics: Androgen Antagonists; Antioxidants; Ascorbic Acid; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Lipid Peroxides; Malondialdehyde; Oxidative Stress; Polycystic Ovary Syndrome; Superoxide Dismutase; Vitamin E | 2008 |
Increased thrombin-activatable fibrinolysis inhibitor antigen levels as a clue for prothrombotic state in polycystic ovary syndrome.
Topics: Adult; Antigens; Carboxypeptidase B2; Cardiovascular Diseases; Case-Control Studies; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Models, Biological; Polycystic Ovary Syndrome; Risk Factors; Thrombosis; Up-Regulation; Young Adult | 2008 |
Androgen dependence of hirsutism, acne, and alopecia in women: retrospective analysis of 228 patients investigated for hyperandrogenism.
Topics: Acne Vulgaris; Adolescent; Adult; Age Factors; Alopecia; Androgens; Androstenedione; Body Mass Index; Cyproterone Acetate; Dehydroepiandrosterone Sulfate; Dose-Response Relationship, Drug; Ethinyl Estradiol; Europe; Female; Follow-Up Studies; Hirsutism; Humans; Oligomenorrhea; Polycystic Ovary Syndrome; Risk Factors; Saliva; Sex Hormone-Binding Globulin; Testosterone; Ultrasonography; Young Adult | 2009 |
Increased follistatin levels after oral contraceptive treatment in obese and non-obese women with polycystic ovary syndrome.
Topics: Adult; C-Reactive Protein; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Ethinyl Estradiol; Female; Follistatin; Humans; Obesity; Polycystic Ovary Syndrome; Prospective Studies | 2010 |
Serum high-sensitivity C-reactive protein and homocysteine changes during hormonal therapy in women with polycystic ovary syndrome: a prospective, matched study.
Topics: Adolescent; Adult; Body Mass Index; C-Reactive Protein; Cyproterone Acetate; Desogestrel; Drug Therapy, Combination; Estrogens, Conjugated (USP); Ethinyl Estradiol; Female; Homocysteine; Humans; Linear Models; Phenotype; Polycystic Ovary Syndrome; Prospective Studies; Statistics, Nonparametric | 2010 |
Endocrinological, metabolic and clinical features of treatment with oral contraceptive formulation containing ethinylestradiol plus chlormadinone acetate in nonobese women with polycystic ovary syndrome.
Topics: Acne Vulgaris; Androgens; Anthropometry; Body Composition; Chlormadinone Acetate; Contraceptives, Oral, Combined; Electric Impedance; Ethinyl Estradiol; Female; Glucose; Glucose Tolerance Test; Hirsutism; Humans; Insulin; Polycystic Ovary Syndrome; Young Adult | 2010 |
Alteration of cardiovascular risk parameters in women with polycystic ovary syndrome who were prescribed to ethinyl estradiol-cyproterone acetate.
Topics: Blood Flow Velocity; Blood Glucose; Brachial Artery; Cardiovascular Diseases; Carotid Intima-Media Thickness; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Cyproterone; Ethinyl Estradiol; Female; Humans; Polycystic Ovary Syndrome; Risk Factors; Testosterone; Triglycerides; Young Adult | 2011 |
Thyroid vein thrombosis in a young woman with methylenetetrahydrofolate reductase gene mutation receiving cyproterone acetate/ethinylestradiol treatment for polycystic ovary syndrome: a case report.
Topics: Adult; Anticoagulants; Contraceptives, Oral, Combined; Cyproterone Acetate; Ethinyl Estradiol; Female; Heparin, Low-Molecular-Weight; Heterozygote; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Mutation; Polycystic Ovary Syndrome; Thyroid Gland; Venous Thrombosis | 2011 |
[The influence of low-dose oral contraceptive pill on clinical and metabolic parameters in young women with polycystic ovary syndrome].
Topics: Adult; Cholesterol; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Drug Therapy, Combination; Estrogens; Ethinyl Estradiol; Female; Humans; Polycystic Ovary Syndrome; Testosterone; Triglycerides; Young Adult | 2011 |
Effects of ethinyl estradiol-cyproterone acetate treatment on metabolic syndrome, fat distribution and carotid intima media thickness in polycystic ovary syndrome.
Topics: Adiposity; Adolescent; Adult; Androgen Antagonists; Body Fat Distribution; Carotid Intima-Media Thickness; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Insulin Resistance; Metabolic Syndrome; Polycystic Ovary Syndrome; Testosterone; Young Adult | 2012 |
Soluble platelet/endothelial cell adhesion molecule (sPECAM)-1 is increased in polycystic ovary syndrome and related to endothelial dysfunction.
Topics: Androstenes; Case-Control Studies; Endothelium, Vascular; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Metformin; Platelet Endothelial Cell Adhesion Molecule-1; Polycystic Ovary Syndrome; Regression Analysis; Reproductive Control Agents; Vasodilation; Young Adult | 2012 |
Effect of an oral contraceptive on emotional distress, anxiety and depression of women with polycystic ovary syndrome: a prospective study.
Topics: Adolescent; Adult; Androstenes; Anxiety; Contraceptives, Oral; Depression; Ethinyl Estradiol; Female; Hirsutism; Humans; Menstruation Disturbances; Polycystic Ovary Syndrome; Prospective Studies; Quality of Life; Stress, Psychological; Surveys and Questionnaires; Treatment Outcome | 2012 |
Ethinyl estradiol-drospirenone vs ethinyl estradiol-drospirenone plus metformin in the treatment of lean women with polycystic ovary syndrome.
Topics: Androstenes; Ethinyl Estradiol; Female; Humans; Male; Metformin; Middle Aged; Polycystic Ovary Syndrome; Thinness | 2013 |
Oral contraceptive containing chlormadinone acetate and ethinylestradiol reduces plasma concentrations of matrix metalloproteinase-2 in women with polycystic ovary syndrome.
Topics: Adolescent; Adult; Androgen Antagonists; Anthropometry; Brazil; Chlormadinone Acetate; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Polycystic Ovary Syndrome; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2; Young Adult | 2012 |
The effects of treatment with drospirenone/ethinyl oestradiol alone or in combination with metformin on elastic properties of aorta in women with polycystic ovary syndrome.
Topics: Adolescent; Adult; Androstenes; Aorta; Body Mass Index; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Metformin; Polycystic Ovary Syndrome; Treatment Outcome; Vascular Stiffness; Weight Loss | 2012 |
Oral contraceptive plus antiandrogen therapy and cardiometabolic risk in polycystic ovary syndrome.
Topics: Adult; Androstenes; C-Reactive Protein; Cholesterol, HDL; Ethinyl Estradiol; Fasting; Female; Glucose Tolerance Test; Humans; Insulin; Polycystic Ovary Syndrome; Prospective Studies; Reproductive Control Agents; Spironolactone; Testosterone; Triglycerides; Young Adult | 2013 |
Severe hyperandrogenemia and insulin resistance in a 12-year-old girl.
Topics: Child; Estrogens; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Hyperinsulinism; Hypoglycemic Agents; Insulin Resistance; Metformin; Polycystic Ovary Syndrome; Testosterone | 2012 |
Aromatase gene polymorphism does not influence clinical phenotype and response to oral contraceptive pills in polycystic ovary syndrome women.
Topics: Adult; Androgens; Anovulation; Aromatase; Blood Pressure; Body Mass Index; Contraceptives, Oral; Ethinyl Estradiol; Female; Gene Frequency; Genotype; Hirsutism; Humans; Hyperandrogenism; Norpregnenes; Phenotype; Polycystic Ovary Syndrome; Polymorphism, Single Nucleotide; Spironolactone; Young Adult | 2012 |
Body composition in lean women with polycystic ovary syndrome: effect of ethinyl estradiol and drospirenone combination.
Topics: Adolescent; Adult; Androstenes; Body Composition; Case-Control Studies; Contraceptives, Oral, Combined; Estrogens; Ethinyl Estradiol; Female; Humans; Mineralocorticoid Receptor Antagonists; Polycystic Ovary Syndrome; Thinness; Young Adult | 2013 |
Differences in the use of combined oral contraceptives amongst women with and without acne.
Topics: Acne Vulgaris; Adolescent; Adult; Androgen Antagonists; Cohort Studies; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Cyproterone Acetate; Drug Prescriptions; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Polycystic Ovary Syndrome | 2003 |
The risk of venous thromboembolism in women prescribed cyproterone acetate in combination with ethinyl estradiol: a nested cohort analysis and case-control study.
Topics: Acne Vulgaris; Adult; Androgen Antagonists; Case-Control Studies; Cohort Studies; Contraceptives, Oral, Combined; Cyproterone Acetate; Estradiol Congeners; Ethinyl Estradiol; Female; Hirsutism; Humans; Odds Ratio; Polycystic Ovary Syndrome; Risk Factors; Thromboembolism; Venous Thrombosis | 2003 |
Effect of two modes of antiandrogen treatment on insulin sensitivity and serum leptin in women with PCOS.
Topics: Adipose Tissue; Adult; Androgen Antagonists; Apolipoproteins A; Apolipoproteins B; Blood Glucose; Body Composition; Body Constitution; Body Mass Index; Body Weight; C-Peptide; Cyproterone Acetate; Dehydroepiandrosterone Sulfate; Ethinyl Estradiol; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Insulin; Insulin Resistance; Leptin; Lipoprotein(a); Obesity; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Testosterone; Triglycerides | 2003 |
The in vitro biosynthesis of estradiol-17 beta-4-C-14 by surviving normal and Stein-Leventhal type ovarian slices.
Topics: Anatomy; Estradiol; Estrone; Ethinyl Estradiol; Female; Humans; In Vitro Techniques; Ovary; Polycystic Ovary Syndrome; Testosterone | 1963 |
URINARY CORTISOL EXCRETION AS A TEST OF ADRENAL CORTICAL FUNCTION.
Topics: 17-Ketosteroids; Addison Disease; Adrenal Glands; Adrenocorticotropic Hormone; Adrenogenital Syndrome; Asthma; Carcinoma, Bronchogenic; Coccidioidomycosis; Cushing Syndrome; Diabetes Mellitus; Ethinyl Estradiol; Female; Humans; Hydrocortisone; Hyperaldosteronism; Hypopituitarism; Hypotension; Myocardial Infarction; Neurotic Disorders; Pituitary Neoplasms; Polycystic Ovary Syndrome | 1964 |
[DRUG THERAPY OF HIRSUTISM].
Topics: Adrenal Hyperplasia, Congenital; Adrenogenital Syndrome; Cushing Syndrome; Drug Therapy; Ethinyl Estradiol; Female; Hirsutism; Humans; Hypertrichosis; Norethindrone; Polycystic Ovary Syndrome | 1964 |
Urinary 6-sulfatoxymelatonin excretion in hyperandrogenic women with polycystic ovary syndrome: the effect of ethinyl estradiol-cyproterone acetate treatment.
Topics: Adolescent; Adrenocortical Hyperfunction; Adult; Androgen Antagonists; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Hirsutism; Humans; Melatonin; Polycystic Ovary Syndrome | 2003 |
Urinary 6-sulfatoxymelatonin excretion in hyperandrogenic women: the effect of cyproterone acetate-ethinyl estradiol treatment.
Topics: Adrenal Hyperplasia, Congenital; Adult; Androgen Antagonists; Case-Control Studies; Cyproterone Acetate; Drug Combinations; Drug Therapy, Combination; Estrogens; Ethinyl Estradiol; Female; Hirsutism; Humans; Hyperandrogenism; Melatonin; Polycystic Ovary Syndrome | 2004 |
Adrenal adenoma and normal androgen levels in a young woman with polycystic ovaries: a case of idiopathic hirsutism?
Topics: Acne Vulgaris; Adenoma; Adolescent; Adrenal Gland Neoplasms; Androgens; Estrogens; Ethinyl Estradiol; Female; Hirsutism; Humans; Norpregnenes; Oligomenorrhea; Ovary; Polycystic Ovary Syndrome; Progestins; Treatment Outcome; Ultrasonography | 2004 |
Serum prostate specific antigen levels in women with polycystic ovary syndrome and the effect of flutamide+desogestrel/ethinyl estradiol combination.
Topics: Adolescent; Adult; Androgen Antagonists; Androgens; Androstenedione; Contraceptives, Oral, Hormonal; Desogestrel; Drug Therapy, Combination; Ethinyl Estradiol; Female; Flutamide; Hirsutism; Humans; Insulin; Luteinizing Hormone; Polycystic Ovary Syndrome; Prostate-Specific Antigen; Testosterone | 2004 |
Venous thromboembolism associated with cyproterone acetate in combination with ethinyloestradiol (Dianette): observational studies using the UK General Practice Research Database.
Topics: Acne Vulgaris; Adolescent; Adult; Androgen Antagonists; Case-Control Studies; Cyproterone Acetate; Databases, Factual; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Humans; Incidence; Polycystic Ovary Syndrome; United Kingdom; Venous Thrombosis | 2004 |
Drospirenone and PCOS.
Topics: Androstenes; Drug Combinations; Ethinyl Estradiol; Female; Humans; Pilot Projects; Polycystic Ovary Syndrome | 2005 |
Determining the time androgens and sex hormone-binding globulin take to return to baseline after discontinuation of oral contraceptives in women with polycystic ovary syndrome: a prospective study.
Topics: Adult; Androgens; Androstenes; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Polycystic Ovary Syndrome; Prospective Studies; Sex Hormone-Binding Globulin; Substance Withdrawal Syndrome; Time Factors | 2007 |
Evaluation of effects of an oral contraceptive containing ethinylestradiol combined with drospirenone on adrenal steroidogenesis in hyperandrogenic women with polycystic ovary syndrome.
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Androstenes; Contraceptives, Oral, Combined; Drug Evaluation; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Polycystic Ovary Syndrome; Prospective Studies | 2007 |
[Effect of 6-month treatment with oral antiandrogen alone and in combination with insulin sensitizers on body composition, hormonal and metabolic parameters in women with polycystic ovary syndrome (PCOS) in order to determine therapeutic strategy].
Topics: Androgen Antagonists; Blood Glucose; Body Composition; Cyproterone Acetate; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Insulin; Lipids; Metformin; Polycystic Ovary Syndrome; Rosiglitazone; Thiazolidinediones; Time Factors; Treatment Outcome | 2006 |
Cyproterone acetate/ethinyl estradiol for acne and hirsutism: time to revise prescribing policy.
Topics: Acne Vulgaris; Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Hirsutism; Humans; Menstruation Disturbances; Polycystic Ovary Syndrome; Practice Guidelines as Topic; Venous Thromboembolism | 2008 |
Metformin and oral contraceptive treatments reduced circulating asymmetric dimethylarginine (ADMA) levels in patients with polycystic ovary syndrome (PCOS).
Topics: Adult; Androgens; Arginine; Body Mass Index; Case-Control Studies; Contraceptives, Oral; Cyproterone Acetate; Ethinyl Estradiol; Female; Gonadotropins; Humans; Insulin Resistance; Metformin; Polycystic Ovary Syndrome; Time Factors | 2008 |
Assessment, diagnosis and treatment of a patient with hirsutism.
Topics: Adult; Androgen Antagonists; Cyproterone Acetate; Ethinyl Estradiol; Female; Hirsutism; Humans; Polycystic Ovary Syndrome; Spironolactone; Ultrasonography | 2008 |
Urinary gonadotropin-inhibiting substance in Stein-Leventhal syndrome and other anovulatory states.
Topics: Adult; Amenorrhea; Chiari-Frommel Syndrome; Child; Ethinyl Estradiol; Female; Gonadotropins; Humans; Hypogonadism; Hypophysectomy; Hypopituitarism; Infertility, Female; Male; Menorrhagia; Metrorrhagia; Polycystic Ovary Syndrome; Pregnancy; Testosterone | 1967 |
[A case of Stein-Leventhal syndrome].
Topics: Adult; Clomiphene; Cyproterone; Cyproterone Acetate; Estrogens, Conjugated (USP); Ethinyl Estradiol; Female; Hirsutism; Humans; Polycystic Ovary Syndrome | 1984 |
Salivary testosterone: relationship to unbound plasma testosterone in normal and hyperandrogenic women.
Topics: Adolescent; Adult; Contraceptive Agents, Male; Cyproterone; Cyproterone Acetate; Ethinyl Estradiol; Female; Hirsutism; Humans; Polycystic Ovary Syndrome; Radioimmunoassay; Saliva; Testosterone | 1982 |
Plasma and salivary androstenedione and dihydrotestosterone in women with hyperandrogenism.
Topics: Adolescent; Adult; Androgen Antagonists; Androstenedione; Cyproterone; Cyproterone Acetate; Dihydrotestosterone; Ethinyl Estradiol; Female; Hirsutism; Humans; Polycystic Ovary Syndrome; Radioimmunoassay; Saliva | 1983 |
Pubertal aberrancy. Etiology and clinical approach.
Topics: Adolescent; Ethinyl Estradiol; Female; Gonadal Dysgenesis; Humans; Hypogonadism; Medroxyprogesterone; Ovulation Induction; Pituitary Hormone-Releasing Hormones; Pituitary Neoplasms; Polycystic Ovary Syndrome; Puberty, Delayed; Surgery, Plastic; Turner Syndrome; Uterus; Vagina | 1984 |
Canalization of human cervical mucus.
Topics: Amenorrhea; Capsules; Cervix Mucus; Chorionic Gonadotropin; Crystallization; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Histological Techniques; Humans; In Vitro Techniques; Luteinizing Hormone; Ovulation; Polycystic Ovary Syndrome; Pregnancy; Progesterone; Time Factors | 1984 |
Ultrasound study of ovarian morphology in women with polycystic ovary syndrome before and during treatment with an oestrogen/progestogen preparation.
Topics: Cyproterone; Ethinyl Estradiol; Female; Humans; Ovary; Polycystic Ovary Syndrome; Ultrasonography | 1983 |
Hirsutism and problem of its management.
Topics: Adolescent; Adult; Allylestrenol; Dexamethasone; Ethinyl Estradiol; Female; Hirsutism; Humans; Polycystic Ovary Syndrome; Progesterone; Retrospective Studies; Spironolactone | 1982 |
Normalization of testosterone levels using a low estrogen-containing oral contraceptive in women with polycystic ovary syndrome.
Topics: Contraceptives, Oral; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Female; Humans; Norethindrone; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Testosterone | 1982 |
Effects of an oral contraceptive containing cyproterone acetate (Diane-35) on the symptoms, hormone profile, and ovarian volume of hirsute women with polycystic ovarian syndrome.
Topics: Adult; Androgen Antagonists; Androgens; Contraceptives, Oral; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Hirsutism; Humans; Luteinizing Hormone; Ovary; Polycystic Ovary Syndrome | 1993 |
Clinical and hormonal effects of gonadotropin-releasing hormone agonist plus an oral contraceptive in severely hirsute patients with polycystic ovary disease.
Topics: Adult; Contraceptives, Oral; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Hirsutism; Humans; Leuprolide; Polycystic Ovary Syndrome | 1996 |
Clinical, endocrinologic, and ultrasonographic features of polycystic ovary syndrome in Singaporean adolescents.
Topics: Adolescent; Adult; Androgen Antagonists; Body Weight; Child; Cyproterone Acetate; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menstruation Disturbances; Ovary; Polycystic Ovary Syndrome; Singapore; Testosterone; Ultrasonography | 1997 |
Comparison of ovarian electrocautery and oral contraceptives in the treatment of hyperandrogenism in women with polycystic ovary syndrome.
Topics: Adult; Androgens; Contraceptives, Oral, Synthetic; Cyproterone Acetate; Desogestrel; Electrocoagulation; Estrogens; Ethinyl Estradiol; Female; Gonadotropins; Humans; Hyperandrogenism; Infertility, Female; Luteinizing Hormone; Ovary; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin | 1999 |
Relapse of hirsutism following long-term successful treatment with oestrogen-progestogen combination.
Topics: Adult; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Follow-Up Studies; Hirsutism; Humans; Polycystic Ovary Syndrome; Recurrence; Retrospective Studies; Sex Hormone-Binding Globulin; Testosterone; Time Factors | 2000 |
Efficacy of the combination ethinyl oestradiol and cyproterone acetate on endocrine, clinical and ultrasonographic profile in polycystic ovarian syndrome.
Topics: Acne Vulgaris; Adult; Case-Control Studies; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Hirsutism; Hormones; Humans; Ovary; Polycystic Ovary Syndrome; Time Factors; Ultrasonography | 2001 |
Insulin action and insulin secretion in polycystic ovary syndrome treated with ethinyl oestradiol/cyproterone acetate.
Topics: Adult; Androgens; Blood Glucose; Case-Control Studies; Cyproterone Acetate; Drug Therapy, Combination; Estradiol Congeners; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Insulin; Insulin Secretion; Luteinizing Hormone; Polycystic Ovary Syndrome; Progesterone Congeners; Secretory Rate; Sex Hormone-Binding Globulin; Testosterone | 2001 |
The influence of combined cyproterone acetate-ethinyl oestradiol therapy on serum levels of dehydroepiandrosterone, androstenedione, and testosterone in hirsute women.
Topics: Adolescent; Adult; Androstenedione; Cyproterone; Dehydroepiandrosterone; Drug Therapy, Combination; Ethinyl Estradiol; Female; Hirsutism; Humans; Middle Aged; Polycystic Ovary Syndrome; Testosterone | 1977 |
Pituitary-ovarian relationships in polycystic ovary syndrome.
Topics: Adult; Androstenedione; Clomiphene; Estradiol; Estrogens; Estrone; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Ovulation; Polycystic Ovary Syndrome | 1977 |
[12 cases of polycystic ovary type 1 (Stein-Leventhal syndrome): complete hormonal study (author's transl)].
Topics: Androstane-3,17-diol; Androstenedione; Clomiphene; Dihydrotestosterone; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Hypothalamo-Hypophyseal System; Luteinizing Hormone; Ovary; Polycystic Ovary Syndrome; Pregnancy; Testosterone | 1978 |
The effect of a low-dose oral contraceptive on serum testosterone levels in polycystic ovary disease.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Female; Humans; Norethindrone; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Testosterone | 1979 |
Abnormalities of ovarian function.
Topics: Androgens; Clomiphene; Estrogens; Ethinyl Estradiol; Female; Humans; Infertility, Female; Ovarian Diseases; Ovarian Function Tests; Ovary; Polycystic Ovary Syndrome; Progesterone; Syndrome; Turner Syndrome | 1976 |
Clinical findings and hormonal responses in patients with polycystic ovarian disease with normal versus elevated LH levels.
Topics: 17-Ketosteroids; Adult; Androstenedione; Chorionic Gonadotropin; Ethinyl Estradiol; Female; Humans; Luteinizing Hormone; Ovary; Oxidoreductases; Polycystic Ovary Syndrome; Testosterone | 1976 |
Oral contraceptives increase insulin-like growth factor binding protein-1 concentration in women with polycystic ovarian disease.
Topics: Adolescent; Adult; Carrier Proteins; Contraceptives, Oral, Hormonal; Cyproterone; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Glucose Tolerance Test; Humans; Insulin; Insulin-Like Growth Factor Binding Proteins; Insulin-Like Growth Factor I; Luteinizing Hormone; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Testosterone | 1991 |
Is plasma 5 alpha-androstane 3 alpha, 17 beta-diol glucuronide a biochemical marker of hirsutism in women?
Topics: Adult; Androgen Antagonists; Androstane-3,17-diol; Biomarkers; Cyproterone; Cyproterone Acetate; Ethinyl Estradiol; Female; Hirsutism; Humans; Middle Aged; Polycystic Ovary Syndrome | 1991 |
The polycystic ovary syndrome presenting as resistant acne successfully treated with cyproterone acetate.
Topics: Acne Vulgaris; Adolescent; Adult; Androgen Antagonists; Cyproterone; Cyproterone Acetate; Dexamethasone; Ethinyl Estradiol; Female; Humans; Polycystic Ovary Syndrome | 1991 |
Long-term treatment with the combination ethinylestradiol and cyproterone acetate in polycystic ovary syndrome.
Topics: Acne Vulgaris; Adult; Alanine Transaminase; Alkaline Phosphatase; Analysis of Variance; Androgen Antagonists; Androstenedione; Aspartate Aminotransferases; Bilirubin; Blood Glucose; Cholesterol; Contraceptives, Oral, Combined; Cyproterone; Cyproterone Acetate; Dehydroepiandrosterone; Dermatitis, Seborrheic; Drug Combinations; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Hirsutism; Humans; Liver; Luteinizing Hormone; Ovary; Polycystic Ovary Syndrome; Prolactin; Sex Hormone-Binding Globulin; Testosterone; Triglycerides | 1990 |
Hirsutism.
Topics: Cyproterone; Drug Therapy, Combination; Ethinyl Estradiol; Female; Hirsutism; Humans; Polycystic Ovary Syndrome | 1990 |
Effects of a low-dose estrogen-antiandrogen combination (Diane-35) on lipid and carbohydrate metabolism in patients with polycystic ovary syndrome.
Topics: Adolescent; Adult; Androgen Antagonists; Apolipoproteins; C-Peptide; Carbohydrate Metabolism; Cholesterol; Cyproterone; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Insulin; Lipid Metabolism; Male; Polycystic Ovary Syndrome; Triglycerides | 1990 |
Effects of a low-dose estrogen-antiandrogen combination (Diane-35) on clinical signs of androgenization, hormone profile and ovarian size in patients with polycystic ovary syndrome.
Topics: Adolescent; Adult; Androgen Antagonists; Androgens; Cyproterone; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Hirsutism; Humans; Luteinizing Hormone; Ovary; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin | 1989 |
Serum testosterone response to low dose dexamethasone and combined contraceptive pill in subgroups of patients with polycystic ovary syndrome.
Topics: Dexamethasone; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Hirsutism; Humans; Norgestrel; Polycystic Ovary Syndrome; Testosterone | 1989 |
Ultrasound study of ovarian and uterine morphology in women with polycystic ovary syndrome before, during and after treatment with cyproterone acetate and ethinyloestradiol.
Topics: Adolescent; Adult; Cyproterone; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Hirsutism; Humans; Menstrual Cycle; Ovary; Ovulation; Polycystic Ovary Syndrome; Time Factors; Ultrasonography; Uterus | 1985 |
Effects of a cyproterone-containing oral contraceptive on hormonal levels in polycystic ovarian disease.
Topics: Contraceptives, Oral, Hormonal; Cyproterone; Cyproterone Acetate; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Humans; Pituitary Hormones; Polycystic Ovary Syndrome | 1987 |
Effect of a combination of ethinylestradiol and desogestrel in adolescents with oligomenorrhea and ovarian hyperandrogenism.
Topics: Adolescent; Androgens; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Humans; Menstrual Cycle; Menstruation Disturbances; Norpregnenes; Oligomenorrhea; Polycystic Ovary Syndrome | 1987 |
Effects of combined desogestrel-ethinylestradiol treatment on lipid profiles in women with polycystic ovarian disease.
Topics: Adolescent; Adult; Cholesterol, HDL; Cholesterol, LDL; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Desogestrel; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Lipids; Lipoproteins; Luteinizing Hormone; Norpregnenes; Polycystic Ovary Syndrome; Testosterone; Triglycerides | 1987 |
Effects of combined ethinylestradiol and desogestrel on hormone profiles and sex hormone binding globulin in women with polycystic ovarian disease.
Topics: Adult; Body Weight; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Gonadotropins, Pituitary; Hormones; Humans; Longitudinal Studies; Menstruation Disturbances; Norpregnenes; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin | 1987 |
[Changes in plasma levels of androgens and SHBG in patients with polycystic ovary syndrome (PCOs) treated with oral contraceptives containing desogestrel].
Topics: Adolescent; Adult; Androgens; Androstenedione; Contraceptives, Oral; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hydroxyprogesterones; Norpregnenes; Polycystic Ovary Syndrome; Progesterone Congeners; Sex Hormone-Binding Globulin; Testosterone | 1988 |
Bioactive LH in women with polycystic ovaries and the effect of gonadotrophin suppression.
Topics: Adolescent; Adult; Desogestrel; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Levonorgestrel; Luteinizing Hormone; Menstrual Cycle; Norgestrel; Norpregnenes; Polycystic Ovary Syndrome; Progesterone; Progesterone Congeners | 1988 |
Pharmacodynamic studies on desogestrel administered alone and in combination with ethinylestradiol.
Topics: Adolescent; Adult; Androgens; Blood Proteins; Desogestrel; Drug Therapy, Combination; Estrogens; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Gonadotropins, Pituitary; Hirsutism; Humans; Libido; Lipids; Norpregnenes; Ovary; Pituitary Gland; Polycystic Ovary Syndrome; Progestins; Sex Hormone-Binding Globulin; Vagina | 1985 |
Influence of endogenous and exogenous oestrogens on posterior pituitary secretion in women.
Topics: Adult; Anorexia Nervosa; Anovulation; Arginine Vasopressin; Ethinyl Estradiol; Female; Humans; Luteinizing Hormone; Menstrual Cycle; Oxytocin; Pituitary Gland, Posterior; Pituitary Hormones; Polycystic Ovary Syndrome; Radioimmunoassay | 1985 |
[In vivo studies on metabolism of androgens following administration of steroidal inhibitors of ovulation. II. Metabolism of radioactive testosterone and dehydroepiandrosterone sulfate in subjects treated with lynestrenol, synthetic estrogens and their co
Topics: Adolescent; Adult; Androsterone; Chromatography, Paper; Dehydroepiandrosterone; Ethinyl Estradiol; Etiocholanolone; Female; Glucuronates; Humans; Hydroxysteroid Dehydrogenases; Lynestrenol; Mestranol; Polycystic Ovary Syndrome; Testosterone | 1966 |
Remission of acanthosis nigricans associated with polycystic ovarian disease and a stromal luteoma.
Topics: 17-Ketosteroids; Acanthosis Nigricans; Adolescent; Adrenocorticotropic Hormone; Androstenedione; Chorionic Gonadotropin; Dexamethasone; Ethinyl Estradiol; Female; Humans; Luteinizing Hormone; Mestranol; Norethindrone; Ovarian Neoplasms; Polycystic Ovary Syndrome; Testosterone; Thecoma | 1974 |
The use of oestrogen-progestogen preparations in the treatment of hirsutism in the female.
Topics: 17-Ketosteroids; Adolescent; Adrenocorticotropic Hormone; Adult; Amenorrhea; Dexamethasone; Ethinyl Estradiol; Ethynodiol Diacetate; Female; Hirsutism; Humans; Mestranol; Obesity; Polycystic Ovary Syndrome; Radioimmunoassay; Testosterone | 1974 |
Effect of estrogen administration on androgen production and plasma luteinizing hormone in hirsute women.
Topics: 17-Ketosteroids; Adolescent; Adult; Amenorrhea; Androstanes; Clitoris; Diethylstilbestrol; Estrogens; Ethinyl Estradiol; Female; Hirsutism; Humans; Luteinizing Hormone; Middle Aged; Norethynodrel; Ovulation; Polycystic Ovary Syndrome; Testosterone | 1970 |
In vivo studies of the motility patterns of the non-pregnant human uterus. II. The effect of oestrogen on myometrial activity.
Topics: Adult; Amenorrhea; Castration; Catheterization; Estrogens; Ethinyl Estradiol; Female; Humans; Intrauterine Devices; Menstruation; Muscle Contraction; Muscle, Smooth; Ovulation; Polycystic Ovary Syndrome; Pregnancy; Progesterone; Uterus | 1968 |
[Influence of sex hormones on the metabolism of androgens].
Topics: Adult; Androgens; Androstanes; Androsterone; Carbon Isotopes; Child; Chorionic Gonadotropin; Enzyme Induction; Enzyme Repression; Estrogens; Ethinyl Estradiol; Etiocholanolone; Female; Glucuronates; Gonadal Steroid Hormones; Hirsutism; Humans; Male; Polycystic Ovary Syndrome; Prostate; Puberty; Sex Factors; Steroids; Sulfates; Testosterone; Tritium | 1969 |